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1. Executive Summary 
1.1. Main conclusions 
This study estimates the alcohol consumption levels associated with two definitions of ‘low risk’ 
drinking which were developed when selecting guideline thresholds in Canada and Australia.  These 
definitions are applied to UK data on alcohol consumption, hospitalisation and mortality alongside 
international epidemiological study evidence within the Sheffield Alcohol Policy Model (v.2.7).  The 
following conclusions for setting a mean daily or mean weekly consumption guideline were found: 
 The Canadian approach sets the guideline threshold at the consumption level where 
population risks and possible benefits of drinking are balanced.  That is, the same number of 
total deaths would occur in the population at this level of drinking as if every person were an 
abstainer, or in other words the net deaths due to alcohol would be zero. Using this 
approach, the implied threshold for males should be between 1.4 and 3.4 units per day 
depending on whether drinkers consume daily or once per week.  The implied threshold for 
females should be between 1.9 and 10.0 units per day.  The latter figure is higher because 
females have low mortality risk for causes which are associated with intoxication.    
 The Australian approach sets the guideline threshold at the consumption level where if 
everyone drank at this level 1% of population deaths would be due to alcohol.  Using this 
approach, the implied threshold for males should be between 2.0 and 6.0 units per day 
depending on whether drinkers consume daily or once per week.  The implied threshold for 
females should be between 2.2 and 12.0 units per day.   
 These estimated implied thresholds are subject to several uncertainties arising from sources 
including underestimation of alcohol consumption, uncertainty over cardioprotective effects 
of moderate drinking and necessary assumptions within the modelling undertaken here.  
The nature and scale of that uncertainty is discussed in this report.  A number of expert 
judgements will be required to select an appropriate guideline threshold based on the wide 
range of evidence available.   
 The estimated thresholds are based on aggregating results from age and gender specific 
risks for all males and all females.  Using the same approaches to derive thresholds for 
specific population groups, such as young adults, is problematic and the research team 
would currently not recommend doing so.  This is because of the different health risks each 
group faces.  For example, while aged 18-24, males have a low absolute risk of mortality and 
a particularly low risk of mortality from chronic disease.  A large proportion of deaths which 
do occur in this age group are due to acute causes (e.g. falls, road traffic accidents) and 
many of these are attributable to alcohol.  As a result, alcohol-attributable deaths would be 
a large proportion of all deaths in this age group even if everyone in the group drank at a low 
level.  Thus the implied guideline under the Australian approach would be very low.  Similar 
problems using the Canadian approach are described in the main report.   
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1.2. Background to this report 
This report was commissioned by Public Health England to inform the UK Chief Medical Officers’ 
review of the country’s lower risk drinking guidelines.  A key challenge in developing such guidelines 
is selecting the consumption level above which drinking is not recommended.  Previous guideline 
development processes in the UK and internationally have often relied on the judgement of expert 
committees, with limited transparency on how evidence informed decision-making.   Seeking to 
address this problem, recent updates of drinking guidelines in Canada and Australia adopted more 
transparent methods.  Guideline consumption thresholds were derived by applying objective and 
clearly stated definitions of ‘lower risk’ to analyses of the risks associated with drinking at different 
levels.   These moves towards greater transparency inform the present report in which the Canadian 
and Australian approaches are adapted and expanded to derive potential guideline thresholds for 
the UK.   
In Canada, the guideline was based around epidemiological evidence suggesting that low levels of 
alcohol consumption are associated with reduced annual risk of mortality when compared with not 
drinking (i.e. there is some evidence that low levels of alcohol consumption provide a ‘protective 
effect’).  The Canadian guidelines for average daily consumption were thus set at the level at which 
risks of drinking were equivalent to those of abstaining from alcohol.  In other words, the threshold 
level was chosen such that, at the population level, the estimated harmful effects and the estimated 
protective effects were counterbalanced equally against each other and net annual mortality risk 
was the same as if everyone abstained from alcohol.  
In Australia, an alternative approach was used which focused on the absolute mortality risk due to 
drinking compared to the mortality risks from other causes.  Thus the Australian guideline was set 
such that if the population all drank at that level, 1% of annual deaths would be attributable to 
alcohol.  Selection of this 1% level was informed by guidance and regulations relating to other 
environmental and health risks and also by risks which appear to be acceptable to the public for 
other activities (e.g. the risk associated with driving a car regularly).   
Although these approaches have the merit of providing a transparent and objective means of 
deriving a guideline threshold, each can be criticised.  For example, the Canadian approach is based 
around protective effects of moderate drinking which are disputed and the Australian approach uses 
a somewhat arbitrary threshold of 1% of deaths being attributable to alcohol.  This report does not 
recommend one approach ahead of the other and instead presents results for both approaches.  It 
also presents additional results based on expansions of each approach (e.g. results are presented for 
the point at which risk reduction relative to abstainers are greatest and the point at which 2% of 
deaths are alcohol attributable).   
1.3. Purpose of this report 
This report has three main aims: 
1. To provide quantified risk estimates for the mortality and morbidity (defined as person-specific 
hospital admissions) associated with different levels and patterns of alcohol consumption for 
drinkers in the UK. 
2. To report the guideline thresholds derived when applying the Canadian and Australian approaches 
to UK mortality and morbidity risk estimates.   
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3. To provide commentary on the limitations of the available evidence and considerations for its use 
in proposing new lower risk drinking guidelines for the UK.   
Recommendation of specific guideline thresholds is not the responsibility of the authors of this 
report.  The report is intended to be used alongside other evidence to inform the deliberations of 
the Guideline Development Group.   
The specific research questions are: 
 For males and females, what would be the estimated relative risk of alcohol-related 
mortality and morbidity associated with different levels and patterns of alcohol 
consumption in the UK population? 
 For males and females, what would be the proportion of all annual mortalities that are 
alcohol attributable for different levels and patterns of alcohol consumption in the UK 
population? 
 What considerations should inform the use of the results in developing new lower risk 
drinking guidelines for the UK general adult population? 
1.4. Overview of methods 
Risk estimates are produced using the Sheffield Alcohol Policy Model (SAPM) v.2.7; a mathematical 
simulation model previously used to appraise UK and international alcohol policy options.  The key 
data inputs into SAPM are baseline levels of current UK alcohol consumption, current levels of 
alcohol-related mortality and morbidity (defined as person-specific hospital admissions) and, most 
importantly, international and UK-specific evidence relating different levels and patterns of alcohol 
consumption to risk of mortality or morbidity from 43 health conditions causally related to alcohol 
consumption.  This evidence is taken from a combination of published meta-analyses of risk 
relationships, analyses of the proportion of cases of alcohol-related conditions attributable to 
alcohol and UK mortality and morbidity rates for the 43 conditions. 
The 43 conditions are divided into four types: 
1. Wholly-attributable, chronic: conditions which cannot occur in the absence of alcohol 
consumption and for which risk of occurrence changes with chronic exposure to alcohol, 
measured here as mean weekly consumption (e.g. alcoholic liver disease).  
2. Wholly-attributable, acute: conditions which cannot occur in the absence of alcohol 
consumption and for which risk of occurrence changes with acute exposure to alcohol 
including intoxication, measured here as peak daily consumption over the previous seven 
days (e.g. ethanol poisoning). 
3. Partially-attributable, chronic: conditions which can occur without alcohol consumption but 
for which the risk of occurrence changes with chronic exposure to alcohol (e.g. cancer of the 
oesophagus).  For a number of primarily cardiovascular conditions within this category, 
lower levels of alcohol consumption are associated with reduced disease risk relative to 
abstainers (a so-called ‘protective effect’) and this is accounted for within SAPM.   
4. Partially-attributable, acute: conditions which can occur without alcohol consumption but 
for which the risk of occurrence changes with acute exposure to alcohol including 
intoxication (e.g. falls).  
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Three sets of risk estimates are derived separately for males and females describing the relationship 
between: 
 Mean weekly consumption and risk of chronic alcohol-related conditions; 
 Peak daily consumption and risk of acute alcohol-related conditions; 
 Mean weekly consumption distributed evenly over one to seven days and risk of all 
alcohol-related health conditions.   
Importantly, the analysis accounts for frequency of drinking (which was incorporated into the 
analysis of mean consumption in Australia but not Canada).  Thus there are seven risk curves drawn 
for males and seven for females, and these curves correspond to whether a given level of mean 
weekly consumption is drunk across 7, 6, 5, 4, 3, 2, or 1 day(s).  The number of drinking days across 
which consumption is distributed affects the balance of chronic risk (due to the mean weekly 
consumption) and acute risk (due to the intoxication effects of drinking on a single day).  Drinking 
ten units per week will accrue more acute risk if consumed on one day as opposed to across several 
days. 
1.5. Summary of main findings 
Table 1 presents the implied lower risk drinking guideline thresholds derived when using the 
Canadian and Australian approaches to analyse mortality risks.  Thresholds are presented as both 
units per week and also units per day as the latter more intuitively demonstrates the effect of 
consumption frequency on the guideline threshold.  
Table 1: Implied lower risk drinking guidelines under different approaches by number of 
drinking days and based on mortality data 
  Units per week Units per day 
Threshold  
Drinking 
days per 
week 
Males Females Males Females 
Canadian: RR=1.0 
1 3.4 10.0 3.4 10.0 
2 5.8 12.0 2.9 6.0 
3 7.4 12.8 2.5 4.3 
4 8.2 13.2 2.1 3.3 
5 8.9 13.4 1.8 2.7 
6 9.4 13.6 1.6 2.3 
7 9.8 13.6 1.4 1.9 
Australian: Proportion deaths 
attributable alcohol=1% 
1 6.0 12.0 6.0 12.0 
2 9.4 14.0 4.7 7.0 
3 11.3 14.8 3.8 4.9 
4 12.3 15.2 3.1 3.8 
5 13.1 15.4 2.6 3.1 
6 13.7 15.6 2.3 2.6 
7 14.1 15.7 2.0 2.2 
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To increase understanding of the absolute alcohol-attributable mortality risk associated with 
different patterns of consumption, Table 2 and Table 3 show for males and females respectively the 
absolute lifetime risk of death as a result of drinking for a range of mean consumption levels and 
frequencies of drinking.   
Table 2: Absolute lifetime risk of male alcohol-attributable mortality by consumption 
frequency and quantity 
Mean 
consumption  
(units/week) 
Drinking days per week 
7 6 5 4 3 2 1 
7 -0.0052 -0.0047 -0.0039 -0.0027 -0.0012 0.0027 0.0142 
14 0.0095 0.0106 0.0121 0.0144 0.0178 0.0252 0.0465 
21 0.0285 0.0300 0.0322 0.0355 0.0409 0.0514 0.0814 
28 0.0511 0.0531 0.0558 0.0599 0.0670 0.0802 0.1178 
35 0.0773 0.0796 0.0829 0.0877 0.0960 0.1114 0.1550 
42 0.1070 0.1097 0.1133 0.1187 0.1277 0.1449 0.1928 
49 0.1403 0.1431 0.1471 0.1529 0.1621 0.1806 0.2312 
 
Table 3: Absolute lifetime risk of female alcohol-attributable mortality by consumption 
frequency and quantity 
Mean 
consumption 
(units/week) 
Drinking days per week 
7 6 5 4 3 2 1 
7 -0.0231 -0.0228 -0.0224 -0.0218 -0.0208 -0.0188 -0.0130 
14 0.0018 0.0023 0.0031 0.0043 0.0061 0.0099 0.0205 
21 0.0367 0.0374 0.0384 0.0400 0.0425 0.0476 0.0625 
28 0.0776 0.0785 0.0797 0.0816 0.0846 0.0907 0.1089 
35 0.1230 0.1240 0.1254 0.1275 0.1309 0.1377 0.1582 
42 0.1720 0.1731 0.1746 0.1768 0.1806 0.1880 0.2096 
49 0.2239 0.2251 0.2267 0.2290 0.2330 0.2408 0.2626 
 
Black text, green background - overall protective effect 
Red text, light orange background - overall lifetime risk less than 1 in 100 
Black text, orange background - overall lifetime risk at least 1 in 100, but below 1 in 10 
White text, red background - overall lifetime risk at least 1 in 10 
 
F1: Using the Canadian approach, the implied drinking guideline for males is between 1.4 units per 
day if drinking every day and 3.4 units per day if drinking once per week (see Figure 6 for the male 
total alcohol-related mortality relative risk curve). 
F2: Using the Canadian approach, the implied drinking guideline for females is 1.9 units per day if 
drinking every day (slightly higher than the male figure of 1.4 units per day) and 10.0  units per day if 
drinking only once per week (see Figure 7 for the female total alcohol-related mortality relative risk 
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curve).  This figure of 10.0 units per day is estimated to be much higher for females than males (3.4 
units per day) and this is because females have much lower absolute risk of acute conditions than 
males, even at high consumption levels.  Thus the implied female threshold differs from the male 
threshold by being more strongly influenced by chronic risks, which are associated with mean 
weekly consumption, and less affected by acute risks, which are influenced by consumption 
frequency.  More generally, it should be noted that acute risks are related to drinking on a single 
occasion and are partly attributable to factors including the drinking context (e.g. at home or in a 
bar) and the characteristics of the drinker.  Thus the estimated threshold of 10.0 units if drinking 
once per week reflects the drinking contexts and drinker characteristics of an average female in the 
population rather than those of specific female drinkers at which any guideline may be targeted.   
F3: The implied thresholds using the Australian approach are all marginally higher than those implied 
using the Canadian approach.  This should be expected as the Canadian approach is based around 
the consumption level at which no deaths are attributable to alcohol and the Australian approach is 
defined by the consumption level at which 1% of annual deaths are attributable to alcohol.  
F4: Using the Australian approach, the implied drinking guideline for males is between 2.0 units per 
day if drinking every day and 6.0 units per day if drinking once per week (see Figure 8 for the male 
total alcohol-related mortality curve showing the estimated proportion of annual deaths which are 
alcohol-related).  
F5: Using the Australian approach, the implied drinking guideline for females is 2.2 units per day if 
drinking every day and 12.0 units per day if drinking once per week (see Figure 9 for the female total 
alcohol-related mortality curve showing the estimated proportion of annual deaths which are 
alcohol-related).  As with the Canadian approach, the 12.0 units per day figure is estimated to be 
much higher than the male equivalent (6.0 units) due to low absolute risk of acute alcohol-related 
mortality among females and the resulting different trade-off of chronic and acute risks when 
compared to males. 
F6: These implied guideline thresholds for males are generally lower than those in the current UK 
lower risk drinking guidelines (assuming at least three drinking days per week) whereas for females 
they are similar to the current guidelines.  The implied guidelines thresholds are also lower than 
those selected in Canada and Australia.   
F7: The current UK guidelines are higher for males than for females whereas the results presented 
here suggest the reverse – that guidelines should be slightly lower for males than females if targeted 
at those drinking on most days (i.e. four or more days a week).  Using the Australian approach, the 
differences between males and females are small and this aligns with the conclusions reached in 
Australia where risks for males and females were found to not be significantly different at the 
consumption levels of interest.  As a result, the resulting Australian guidelines did not distinguish 
between males and females.    
F8: Findings F1 to F5 all consider the male or female population as a group and essentially average 
the different risks faced by people aged 18 through to 89.  Risk curves actually vary substantially by 
age and there are particular age differences in both the balance of acute vs. chronic risks and the 
underlying absolute level of health risk.  These differences create problems for the Canadian and 
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Australian approaches and suggest they are not well-suited to deriving age group-specific guideline 
thresholds.   
For example, younger age groups (i.e. 18-24, 25-34) have very low absolute mortality risk and 
particularly low chronic disease mortality risk, including for cardiovascular diseases.  This means 
potential cardioprotective effects have only a minor effect at very low consumption levels when 
calculating this age group’s mortality risk across all alcohol-related conditions.  Instead, the alcohol-
related mortality risk curve is dominated by the acute risks which account for most alcohol-related 
mortality at younger ages.  Therefore, any guideline threshold derived for the under-35s using the 
Canadian approach would be very low.  Similarly, under the Australian approach, younger age 
groups’ combination of very low absolute mortality risk but relatively high acute alcohol-attributable 
mortality risk means alcohol-attributable deaths account for a large percentage of total deaths in 
this age group.  An age-specific guideline threshold derived using the Australian approach which is 
based on the ratio of alcohol-attributable deaths and total deaths, would therefore also be very low.  
If the Guideline Development Guide wished to derive age-specific guideline thresholds, then one 
alternative would be to consider methods based around each age group’s absolute annual risk of 
mortality.  However, the appropriate method for deriving a guideline threshold under such an 
approach is unclear.  The Australian 1 in 100 mortality risk could be adapted, although it is 
questionable whether the conceptual rationale underlying this definition of acceptable lifetime risk 
can be considered equally valid for annual risk and for risk at specific ages.   
F9: Evidence that lower levels of alcohol consumption are associated with reduced mortality risks for 
cardiovascular disease exerts a strong influence on implied guideline thresholds derived under the 
Canadian and Australian approaches.  This is because the apparent cardioprotective effects of 
moderate drinking influence the shape of the overall alcohol-related mortality risk curve.  However, 
beyond this, potential health benefits of moderate drinking have only limited relevance when 
selecting population-level lower risk drinking guidelines.  This conclusion is based on balancing four 
findings. 
First, although reduced alcohol-attributable mortality risks at lower consumption levels remain after 
accounting for risks from other alcohol-related conditions where there is no evidence of protective 
effects, the level of risk reduction relative to abstainers is low.  The lowest relative risk of mortality 
compared to abstainers is 0.97 for females and 0.99 for males.  This risk reduction is associated with 
very low levels of consumption, namely 2.4 units per week for males drinking daily and 3.4 units per 
week for females drinking daily (see Table 14).  
Second, the Canadian approach derives a guideline threshold from the consumption level where 
there are no further reduced mortality risks. The analyses presented here suggest very small risk 
reductions for alcohol-related mortality persist up to 9.8 units per week for males drinking daily and 
13.6 units per week for females drinking daily (see Figure 6 and Figure 7). 
Third, independent of alcohol consumption, people of each age and sex are at a different level of 
baseline risk for mortality from any cause and from each specific alcohol-related cause.  This means 
risk reductions related to cardiovascular disease are of different importance to each demographic 
group’s overall mortality risk.  Analysis of variation in alcohol-related risk by age suggests that 
cardioprotective effects are only sufficient to provide substantial risk reductions from low levels of 
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drinking for females aged over 55 (see Figure 15).  For other groups, risk reductions for 
cardiovascular conditions are either largely or wholly outweighed by risk increases for other 
conditions. 
Fourth, strong concerns over the robustness of the evidence base for cardioprotective effects mean 
that, even for older females, mortality risk reductions from moderate alcohol consumption may be 
minimal or absent.  
F10: The sensitivity analyses suggest the implied guideline thresholds and the risk curves from which 
they are derived are sensitive to the use of alternative assumptions within the modelling which 
underpins them.  For most sensitivity analyses (e.g. modelling a ten year time period, assuming 
lower CVD mortality rates, varying the threshold within the Australian approach) the size of variation 
in implied guideline thresholds from the base case is of the order of three units per week.  However, 
for other sensitivity analyses (e.g. reintroducing threshold effects used in previous versions of SAPM, 
assuming no cardioprotective effects from moderate alcohol consumption) the variation in results 
from the base case are larger and of the order of ten units per week. These results suggest the base 
case should not be accepted uncritically as the implied guideline thresholds are sensitive to 
alternative assumptions and baseline data and there are not strong arguments for preferring the 
base case specifications over those used in the sensitivity analyses.   
 
1.6. Considerations for using the results to inform selection of new lower 
risk drinking guideline thresholds 
It is beyond the scope of this project report to make specific recommendations on appropriate 
guideline thresholds or to specify the processes the Guideline Development Group should follow 
when using this report.  Nonetheless, a number of expert judgements will be required by the group 
to translate the model results and other available evidence into a proposed guideline threshold.  
Despite the recent shift in international guideline development processes away from ‘opaque 
collective expert opinion’ and toward transparent empirically-driven methods, such judgements 
cannot be avoided and any guidelines which emerge from the review process will reflect 
considerations beyond the numerical analyses presented in this report.  Thus, the final guideline 
should represent a holistic expert judgement by the Guideline Development Group accounting for 
the modelling results, the various points of discussion raised throughout this report and further 
evidence sources and considerations identified in the group’s wider deliberations.   
Based on analysis of the limitations of the research literature on alcohol epidemiology and of SAPM 
itself, the following considerations should usefully inform that judgement.  
C1: Clear and scientifically-robust conclusions can be drawn regarding the broad levels of risk 
associated with different levels and patterns of alcohol consumption.  The level of risk for a given 
level of mean weekly consumption varies depending on the consumption pattern (e.g. weekly vs. 
daily) as this alters the balance of acute and chronic risks the drinker is exposed to.   
C2: Despite this, the consumption levels at which the Canadian and Australian definitions of low risk 
drinking are exceeded are subject to uncertainty due to limitations in the available evidence.  In 
some cases expert judgements can be made to assess the likely direction of effect on risk estimates 
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of these limitations.  In other cases, evidence available in the research literature offers a partial 
understanding of the nature and scale of uncertainty.  This evidence can be considered alongside the 
results presented here when selecting lower risk drinking guideline thresholds.   
C3: The nature and level of risk associated with a given consumption level or pattern varies markedly 
across the population.  Results presented here demonstrate this for gender and age but similar 
points apply to other characteristics (e.g. socioeconomic status, health status, genetic profile).  As a 
result, it is not recommended that either the Canadian or Australian approach are used to derive 
age-specific guidelines.  The Guideline Development Group may also wish to consider whether the 
rationale for these approaches is undermined if the population guideline is derived from averaging 
highly diverse risks across the population and does not correspond to the risk profile of some groups 
of interest.   
C4: Public health guidelines must inevitably strike a balance between being specific enough to reflect 
variations in risk across the population and remaining sufficiently broad to be communicable via 
population-level health promotion campaigns.  One approach to addressing heterogeneity in risks is 
for the Guideline Development Group to consider who the key target populations for each guideline 
are and, where population-level guidelines are used (e.g. on bottle labels or television advertising 
where space is limited), ensure the guidelines are appropriate for those target populations.   
C5: Alcohol consumption is associated with a wide range of risks.  This report addresses mortality 
and morbidity from alcohol-related health conditions; however, alcohol is also strongly associated 
with outcomes including crime, income and employment, family well-being, individual well-being (in 
both positive and negative ways) and child development.  The Guideline Development Group should 
give consideration to these factors alongside the risks for health conditions modelled here.  
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2. Introduction 
In 2012 the UK Chief Medical Officers (CMO) began a review of the country’s lower risk drinking 
guidelines.  An expert advisory group, hereafter the ‘Guideline Development Group’, was appointed 
to provide scientific guidance, make recommendations on whether new guidelines should be 
developed and, if so, advise on what they should be.  To inform the Guideline Development Group’s 
considerations, Public Health England commissioned the University of Sheffield to conduct analyses 
quantifying the risks to UK drinkers associated with different levels and patterns of alcohol 
consumption.  This report presents the methods and findings for those analyses alongside advisory 
commentary on their limitations and considerations for their use in developing revised lower risk 
drinking guidelines.  
2.1. Current use of lower risk drinking guidelines 
Public health guidance on alcohol consumption is provided by Government bodies in most 
developed countries.1  Such guidance is argued to serve multiple functions including informing the 
public about scientific evidence on the risks of drinking, encouraging lower levels of consumption 
and providing a standard against which health professionals can assess patient behaviour and 
discuss it with them.1,2  Guidance usually takes the form of guidelines regarding ‘low risk’, ‘no risk’ or 
‘safe’ levels of alcohol consumption over a given time period, usually a day or week.  The current UK 
drinking guidelines for the general population state: 
“Men should not regularly drink more than 3-4 units a day and women 2-3 units a day where 
regularly means drinking this amount most or every day.”1 
In some countries, separate guidelines are provided for regular consumption and consumption on a 
single occasion, for men and women and for high risk groups such as the young, the elderly and 
pregnant women.3  The focus of this report is on providing evidence to inform gender-specific low 
risk guidelines for both regular and single occasion drinking within the UK general adult population.    
2.2. Setting guideline levels 
A key challenge for those developing or revising lower risk drinking guidelines, is selecting the 
consumption level at which the guideline should be set.  No internationally-agreed threshold exists 
and variations between countries in drinking patterns, underlying risks to health and population 
demographics mean an international standard is not recommended.4  However, there is also no 
agreement on the appropriate processes for setting a threshold in a single country, although steps 
towards this have been taken in recent years and these are briefly summarised below.     
The terms ‘no risk’ and ‘safe’ drinking guidelines have largely been abandoned in favour of ‘low risk’ 
drinking guidelines.  This reflects increased evidence of associations between low-level alcohol 
consumption and several diseases such as cancers of the mouth, throat, breast and digestive 
system.5  However, adoption of the term ‘low risk’ creates a problem as definitions of what 
constitutes a low risk are subjective and risks are also context-specific.  For example, different 
drinkers may be willing to accept greater or lesser degrees of risk and the risks of consumption on a 
single occasion depend on where the drinking takes place and the characteristics of the drinker.   
Commentary on previous guideline development processes acknowledges that when attempting to 
define low risk and select a guideline consumption level, the opinions and values of health experts 
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have often played an important role.  For example, public health researchers involved in developing 
guidelines for Australia have argued: 
“For most specific diseases and for injuries, there is no basis at all in the data for a particular 
cut-off [threshold]… Committees seem to have drawn a deep collective breath and simply 
voted for specific cut-off levels.  Particularly for cut-offs for single-occasion drinking… 
drawing the line is a matter of opaque collective expert opinion”.5 p.137  
In light of these concerns, recent drinking guideline review processes in Canada and Australia sought 
to develop more transparent and empirically-based approaches.   
2.2.1. The Canadian approach 
The Canadian approach was based around the ‘j-curve’ seen when plotting all-cause mortality risks 
against levels of alcohol consumption.6  The j-shape is attributable to the purported protective effect 
of moderate drinking against heart disease and other cardiovascular conditions (see Figure 1 and 
Box 1).   To derive a guideline threshold, the Canadian group argued that low risk could be defined as 
the point “where potential benefits and risks were balanced for the average person in comparison 
with lifetime abstainers”.7 p.126  As shown in Figure 1, the threshold was thus set at the point where 
the j-curve crosses the Relative Risk = 1 line.  In other words, the point where drinking more alcohol 
would lead to a higher risk compared to an abstainer and drinking less alcohol would lead to a lower 
risk compared to an abstainer.  
 
 
Figure 1: Example of the j-curve for relative risks of alcohol consumption 
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2.2.2. The Australian approach 
A different approach was used in Australia where low risk was defined with reference to: (a) other 
official standards on environmental and health risks and (b) evidence on the risks associated with 
other everyday activities such as driving a car.  A full discussion of these considerations is available in 
the Australian guideline development group’s report.8  Briefly, most environmental risk thresholds 
permit only very small risks.  For example, in Australia, water toxins are not permitted in 
concentrations which would lead to more than one additional cancer per million people if consumed 
across a life time (i.e. a 1 in 1,000,000 risk threshold).5  Application of such thresholds to alcohol 
consumption would lead to advising virtually no drinking.  However, most of these environmental 
risk thresholds are set to ensure industry does not harm the public.  An alternative threshold is one 
aimed at preventing individuals from harming themselves, such as thresholds determining the point 
at which Government should intervene and remove the public’s choice to make their own risk 
decisions. The Australian guideline development group referred to Australian regulations allowing 
the forcible removal of people from their homes to avoid radioactive contamination if the risk of 
death was 1 in 100.  However, as this threshold determines when risk is sufficiently high for 
Government to remove people’s freedom to make their own health decision, it is still an imperfect 
basis for deriving a lower risk drinking guideline.  Finally, the Australian group noted that a 1996 
paper found the lifetime risk of dying in a traffic accident in the US for someone who drives 10,000 
miles a year was estimated to be 1 in 60,8,9 suggesting this is perceived by the public, to the extent 
they are aware of it, as an acceptable risk.  Based on these public behaviour and environmental 
safety standards, it was concluded that an acceptable risk, and thus ‘low risk’, for voluntary activities 
such as drinking can reasonably be defined as a 1 in 100 lifetime risk of dying from the activity.  For 
the present purposes, this can be alternatively phrased as the consumption level within the 
population below which no more than 1% of all deaths are attributable to alcohol. 
2.2.3. Comparison and critique of the Canadian and Australian approaches 
Although both approaches are more transparent than many previous guideline development 
processes, neither the Canadian or Australian approach is wholly satisfactory.  For example, the 
Australian approach retains considerable subjectivity in its selection of the 1 in 100 threshold3 and 
relies for this on the limited available evidence on acceptable risks.  There is also no particular 
reason why low risk should be defined using a round number and not 1 in 82 or 1 in 137 and using 
these alternative but equally valid thresholds may affect the guideline consumption levels.  
Moreover, the Australian group acknowledge that their definition of low risk is partly based on 
previous environmental standards.8  These relate imperfectly to the nature and purpose of public 
Box 1: The j-curve. 
The j-curve refers to the shape of the curve formed by a graph plotting mean grams of alcohol 
consumed per day against risk of mortality from alcohol-related causes and particularly from 
cardiovascular diseases.  At low levels of consumption, the mortality risk for many 
cardiovascular diseases is consistently observed to be less than the risk for abstainers.  This 
suggests that moderate drinking may protect against cardiovascular disease.  However, this 
interpretation of the finding is contested by many researchers who point to a lack of well-
evidenced biological processes which could explain the effect.  There are also concerns about 
the research methods which lead to the finding and these are discussed in the Discussion 
section of this report.   
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health guidance and are also themselves somewhat arbitrary in their selection of threshold values; 
as evidenced by the consistent use of round numbers.  
Furthermore, neither approach provides a method for selecting a guideline for single drinking 
occasions (also known as a binge drinking guideline).  Under the Canadian approach, there is no j-
curve for risks linked to single occasions (e.g. risks of injuries) and the report of the Canadian 
Guideline Development Group  offers no rationale linking the evidence reviewed on single occasion 
drinking and the guideline eventually selected.6  The Australian approach also cannot be 
straightforwardly used to derive a single occasion drinking guideline as it relies on modelling which 
combines adding up risks across multiple drinking occasions into an annual or lifetime risk.  The 
Australian Guideline Development Group reverted to reviewing the literature when selecting a single 
occasion guidelines and identified an apparent threshold effect whereby risks from a single drinking 
occasion began to increase more rapidly above 4 Australian standard drinks (5 UK units) for both 
males and females.  
Both approaches also prompt questions regarding how they would be applied if emerging evidence 
substantially revises estimated health risks and thus the derived guideline threshold.  This problem is 
perhaps clearest for the Canadian approach which explicitly links the drinking guideline to evidence 
of cardioprotective effects from moderate drinking.  These effects are disputed,10-13 may be 
overestimated14-17 and are probably limited to particular groups within society18 (see Section 
5.4.1.2).  If, as appears possible, scientific opinion develops to conclude cardioprotective effects are 
in fact overestimated and only occur up to very low levels of consumption (e.g. 5 units per week); 
one of the researchers responsible for the Canadian approach concluded that this would leave the 
Canadian guideline “in trouble”.19 p.1547    
A further point of debate is whether it is more appropriate to set public health guidance using a 
‘relative risk’ approach, as in Canada, or an ‘absolute risk’ approach, as is used in Australia (see Box 
2).  The Canadian relative risk approach suggests judgements of whether drinking is risky should be 
made with reference to the risk experienced by abstainers.  However, the public may wish to know 
what their absolute level of risk is rather than considering how much extra risk they are willing to 
accept compared to ‘the average abstainer’.  This is particularly the case given the average abstainer 
is a statistical construct rather than a real person and one which represents a group (i.e. alcohol 
abstainers) who tend to be different from the general population in ways which extend beyond not 
consuming alcohol.20-25  In contrast, the Australian approach is, to an extent, based on the absolute 
level of risk experienced by drinkers.  However, many different guidelines would be required to 
satisfactorily account for the substantial variation in absolute risk which is seen across the 
population.  For example, the risk of alcohol-related mortality in the next ten years is much higher 
for a 60-year-old compared to a 20-year-old drinking at the same level.  Further large variations 
depend on characteristics such as social status, genetic profile, psychological predispositions and 
engagement in other healthy or unhealthy behaviours.   
Despite these limitations, the Canadian and Australian approaches are currently regarded as the best 
available methods for deriving guideline thresholds from evidence on alcohol-related health risks.  
This is largely because they provide a transparent and empirical basis for selecting the threshold 
rather than relying on the “opaque collective expert opinion”5 p.137 which has been acknowledged in 
previous public debate26 and potentially undermines public faith in guidelines.  
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2.3. Purpose of this report 
To inform the considerations of the Guideline Development Group, this report provides estimates of 
the health risks associated with different levels and patterns of alcohol consumption for UK drinkers.  
It also provides commentary on the limitations of those estimates and considerations for their use in 
proposing new lower risk drinking guidelines for the UK.  Recommendation of specific guideline 
thresholds is outside of the scope of the report, but the guideline thresholds derived from applying 
the Canadian and Australian approaches to the risk estimates will be indicated.  A limited set of 
further analyses are conducted examining the sensitivity of the results to alternative evidence, 
assumptions and methodologies.  Sensitivity analyses will also examine how alternative versions of 
the Canadian and Australian approaches affect the derived guideline thresholds (e.g. if the 
Australian threshold is set at 2% of annual deaths being alcohol attributable instead of 1%).   
The specific research questions answered are: 
1. For males and females, what levels of relative risk of alcohol-related mortality and morbidity 
are associated with different levels and patterns of alcohol consumption in the UK 
population? 
2. For males and females, what proportions of all annual mortalities are alcohol attributable for 
different levels and patterns of alcohol consumption in the UK population? 
3. What considerations should inform the use of the results in developing new lower risk 
drinking guidelines for UK general adult population? 
Box 2: Relative risk and absolute risk 
Levels of risk can be presented in different ways and two of the most common ways are 
relative and absolute risk.   
Absolute risks describe the risk (or probability) of experiencing an outcome over a given time 
period.  Someone drinking 10 units a week might have an absolute risk of 0.05 (i.e. a 5% or 1 in 
20 chance) of dying in any given year.   
Relative risks are used to compare risk of a particular outcome in two groups of people. In 
alcohol research, this usually means comparing the risk of drinking at a particular level to the 
risk of not drinking.  For example, drinking 10 units a week may be associated with a relative 
risk of 1.7 for dying in any given year.  This would usually mean people drinking 10 units a week 
are 1.7 times more likely than abstainers to die in any given year.  If drinking is less risky than 
not drinking, the relative risk will be less than one.  For example, a relative risk of 0.5 for 
drinking 10 units a week would mean people drinking that amount are half as likely to 
experience the outcome as abstainers. 
Both ways of presenting risks are useful for alcohol research.  Absolute risks tell us something 
about whether we are likely to experience an outcome as a result of different levels of drinking 
(e.g. if you drink that amount you have a 12% risk of dying from your drinking).  Relative risks 
are useful because they provide a way of comparing risks across different levels of behaviour 
(e.g. if you increase your drinking by that amount, you are doubling your risk of dying from it). 
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3. Methodology 
3.1. Overview of the modelling approach 
The Sheffield Alcohol Policy Model (SAPM) v.2.7 is used to estimate risk curves (similar to Figure 1) 
describing the relationship between alcohol consumption and risks of mortality or morbidity from 
alcohol-related health conditions.  Morbidity is defined here as person-specific hospital admissions 
which means if an individual is hospitalised for more than one cause or more than once in a year, 
they are only counted once.   
SAPM is a mathematical simulation model which has previously been used for appraising UK and 
international alcohol policy options.27-32  It comprises two main components.  The first component 
estimates the impact of policy changes on alcohol consumption (P2C) and the second component 
estimates the impact of consumption changes on rates of alcohol-related harm including health 
conditions, crime and workplace absenteeism (C2H).  For the present analysis, only the C2H model 
examining health conditions is required.   
The risk curves are created by using the C2H component of SAPM to estimate the absolute level of 
mortality and morbidity for alcohol-related conditions occurring in a single year under the 
assumption that the UK population all drink at the same level.  The results are then converted into 
risk estimates by comparing the results when the level the population all drinks at is varied.   
Risk curves are derived describing the relationship between: 
 Mean weekly consumption and risk of chronic alcohol-related conditions (see Table 4); 
 Single occasion consumption and risk of acute alcohol-related conditions (see Table 4); 
 Mean weekly consumption distributed over one to seven days and risk of all alcohol-related 
health conditions. 
For each of the above, separate risk curves are derived for males and females and, where available 
data permit, for mortality and morbidity.  In all cases, risks curves are derived allowing for the 
Canadian approach to be used to identify an implied guideline threshold, as described in the 
Introduction (Section 2.2.1).  This means risk curves where the y-axis is the modelled population’s 
average annual relative risk of mortality or morbidity for the relevant alcohol-related conditions.  For 
the third set of risk curves (mean weekly consumption distributed over one to seven days and risk of 
all alcohol-related health conditions), risk curves are derived which allow the Australian approach to 
be used to derive an implied guideline threshold via the method described in the Introduction 
(Section 2.2.2).  For the Australian approach, the y-axis broadly relates to the proportion of 
mortalities which are alcohol attributable although the exact definition of the y-axis varies 
depending on the outcome under examination.  Morbidity risk curves using the Australian approach 
are not derived as the necessary data are not held by the University of Sheffield (see Section 3.2.2).   
A small number of adaptations to the previously published SAPM v.2.627 are required to enable 
these analyses to be performed for the UK.  These adaptations are: 
 A UK-wide version of SAPM is required as previous analyses have used separate models for 
each UK country.27,33-35 
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 Variations in alcohol-related health risk by socioeconomic status are not accounted for as 
socioeconomic status measures which are comparable between countries are not available 
within the input data used. 
 Time lags describing the delay between changes in population-level consumption and 
changes in rates of alcohol-related health outcomes are not modelled as how population 
health changes over time is not a focus of the present analysis 
 A revised model of the relationship between single occasions of drinking and health 
outcomes described by Hill-McManus et al.36,37 is not used here although it is included in 
other forthcoming reports based on SAPM analyses.  This is because the revised model 
accounts for a range of sociodemographic variables (e.g. education, ethnicity, number of 
children) in estimating annual drinking patterns.  The modelling approach used for this 
report requires that all individuals in the population of interest (i.e. all men or all women) 
have the same consumption patterns. 
Sensitivity analyses are described in Section 3.7 and examine: 
 The effect of alternative assumptions regarding the consumption level above which risks for 
acute alcohol-related harms begin to increase; 
 The effect of assuming alcohol consumption at any level does not reduce risks of any health 
condition; 
 The effect of modelling different time periods; 
 The effect of accounting for recent trends in cardiovascular mortality; 
 The effect of using alternative thresholds linked to the Canadian and Australian approaches. 
3.2. Data  
The present analyses estimate risk curves under hypothetical scenarios where uniform consumption 
levels are assigned to the population.  However, recent datasets detailing individual-level alcohol 
consumption and incidence of alcohol-related mortality and morbidity are still required to derive 
inputs to the model.  Data on population demographics are also required to create accurate 
weighted averages of risk levels across the population.   
Previous versions of SAPM have built separate country-specific model adaptations using data from 
each UK country (i.e. England, Scotland, Wales and Northern Ireland).27,33-35  In the present analysis, 
a UK-wide SAPM is required meaning country-specific data must be combined or UK-wide datasets 
sourced. 
3.2.1. Consumption data 
Prior to 2011, the General Lifestyle Survey (GLF) provided large sample, nationally-representative 
individual self-report data on alcohol consumption in the UK.  These data have been the key input to 
previous version of SAPM.  However, funding for the alcohol questions in the GLF was discontinued 
with immediate effect in mid-2011, meaning the last full year sample was 2010. No suitable 
alternative UK-wide dataset was available, therefore UK-wide consumption data are obtained by 
combining data from the most recent large sample surveys in each UK country.  These are: 
 England: Health Survey for England, 2012.  
 Scotland: Scottish Health Survey, 2012.  
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 Wales: General Lifestyle Survey, 2008-2011 (pooled, Welsh samples only) – used because 
the Welsh Health Survey does not measure mean weekly alcohol consumption and the 
sample size is increased by using three surveys.  
 Northern Ireland: Health Survey Northern Ireland, 2010/11 and 2011/12 (pooled) – two 
surveys are used to increase the sample size.  
To obtain an analytical dataset containing consumption data representative of the UK population, 
the existing weights in the survey datasets are adjusted to match the population distribution across 
age, sex and UK country based on Office for National Statistics (ONS) mid-year 2013 population 
estimates.38   
Each survey provides data on respondents’ mean weekly alcohol consumption in UK units (1 unit = 
8g/10ml pure ethanol).   These data are derived using beverage-specific quantity frequency 
questions which ask (a) how often respondents drink each of a set of beverage types (frequency) and 
(b) how much of each beverage type they consume on a typical occasion when they drink it 
(quantity).  Quantities are converted into units of alcohol using standard ONS assumptions39 and the 
frequency and quantity are multiplied and then summed across beverages to give mean weekly 
consumption.  Consumption is capped at a maximum value of 300 units per week as the evidence 
used on health risks is less robust for those drinking at extremely high levels.  
With the exception of the Health Survey Northern Ireland (HSNI), each survey also provides data on 
respondents’ heaviest drinking day in the week preceding the survey.  This is collected by identifying 
the day in the preceding week on which the respondent consumed the most and asking how much 
they consumed on that day of each of a set of beverage types.  Consumption on the heaviest 
drinking day in the preceding week (hereafter peak daily consumption) provides a measure of binge 
or single occasion drinking behaviour.   
For Northern Ireland, peak daily consumption is imputed using Predictive Mean Matching40 within 
the combined survey data for England, Scotland and Wales. Under this method, individuals in the 
HSNI are allocated the peak daily consumption of the individual in the combined English, Scottish 
and Welsh dataset who provides the closest match in terms of mean weekly consumption, and a set 
of sociodemographic variables. Where multiple closest matches are identified, one is selected at 
random. All analyses were performed in Stata 1241 using the mi impute pmm command. Whilst this 
process introduces additional uncertainty into the baseline data used in the modelling, the overall 
impact of this is likely to be small as Northern Ireland accounts for less than 3% of the baseline 
modelled population 
3.2.2. Alcohol-related health condition data 
The University of Sheffield hold data providing mortality and morbidity rates for alcohol-related 
health conditions in each UK country corresponding with the years of the consumption surveys.  For 
England, all-cause and condition-specific mortality rates are derived from ONS mortality statistics for 
England and Wales,42 while alcohol-related condition-specific morbidity rates are based on person-
specific hospitalisations from the Hospital Episodes Statistics (HES) database as calculated by Jones 
and Bellis.43   For Scotland, Wales and Northern Ireland, equivalent mortality and morbidity data 
were provided by the respective devolved governments.   
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For the present analyses, the denominators of the mortality and morbidity rates are adjusted to 
match the population distribution across age, sex and UK country given by ONS mid-year 2013 
population estimates.38  
Northern Ireland data were not available for three health conditions: (1) maternal care for 
(suspected) damage to foetus from alcohol, (2) tuberculosis and (3) lower respiratory infections: 
pneumonia.  Therefore, UK mortality and morbidity rates for these conditions are calculated as rates 
for England, Scotland and Wales only.  The impact of this on the model results is likely to be small as 
these three conditions have a relatively small number of alcohol-attributable cases. 
3.3. Model structure 
An epidemiological approach is used within SAPM to model the relationship between alcohol 
consumption and related harm.  Therefore, risk functions relating mean weekly and peak daily 
consumption to level of risk for a set of 43 alcohol-related health conditions are the fundamental 
components of the model.   
3.4. Health conditions included in the model 
Table 4 presents the 43 alcohol-related health conditions included within SAPM and for which 
evidence suggests alcohol plays a contributory role.  This has been adapted from recent global meta-
analyses and burden of disease studies.44,45  The conditions are divided into four categories 
delineating those which are wholly or partly due to alcohol and those which are primarily due to 
chronic or acute alcohol consumption: 
1. Wholly-attributable, chronic: conditions which cannot occur in the absence of alcohol 
consumption and for which risk of occurrence changes with chronic exposure to alcohol, 
measured here as mean weekly consumption (e.g. alcohol liver disease).  
2. Wholly-attributable, acute: conditions which cannot occur in the absence of alcohol 
consumption and for which risk of occurrence changes with acute exposure to alcohol 
including intoxication, measured here as peak daily consumption over the previous seven 
days (e.g. ethanol poisoning). 
3. Partially-attributable, chronic: conditions which can occur without alcohol consumption but 
for which the risk of occurrence changes with chronic exposure to alcohol (e.g. cancer of the 
oesophagus).  For a number of primarily cardiovascular conditions within this category, 
lower levels of alcohol consumption are associated with reduced disease risk relative to 
abstainers (a so-called ‘protective effect’) and this is accounted for within SAPM.   
4. Partially-attributable, acute: conditions which can occur without alcohol consumption but 
for which the risk of occurrence changes with acute exposure to alcohol including 
intoxication (e.g. falls).   
3.5. Derivation of risk functions 
The relationship between alcohol consumption and health outcomes was examined differently for 
each of the four health condition categories. 
3.5.1. Relative risk functions for partially-attributable chronic conditions - available in 
the published research literature 
The relative risk functions linking mean weekly consumption to all chronic conditions that are 
partially attributable to alcohol are shown in Figure 2 and sources from within the published 
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research literature are shown in Table 4.  These risk functions are taken from studies which 
systematically review and meta-analyse the evidence base.  Where available, separate risk functions 
by gender and for mortality and morbidity were extracted from the literature and these are shown 
in Figure 2, otherwise the same risk function was assumed for both genders and/or outcomes.  
 
Table 4: Health conditions included in SAPM v.2.7 and sources for risk functions 
Category Disease or injury ICD-10 codes Source for risk 
function 
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Alcohol-induced pseudo-Cushing's syndrome E24.4  
Degeneration of nervous system due to alcohol G31.2 
Alcoholic polyneuropathy G62.1 
Alcoholic myopathy G72.1 
Alcoholic cardiomyopathy I42.6 
Alcoholic gastritis K29.2 
Alcoholic liver disease K70.0-K70.4, K70.9 
Acute pancreatitis (alcohol induced) K85.2 
Chronic pancreatitis (alcohol induced) K86.0 
Maternal care for (suspected) damage to foetus from alcohol O35.4 
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) Mental and behavioural disorders due to use of alcohol F10 
Excessive Blood Level of Alcohol R78.0 
Toxic effect of alcohol T51.0, T51.1, T51.8, T51.9 
Accidental poisoning by exposure to alcohol X45 
Intentional self-poisoning by and exposure to alcohol X65 
Poisoning by and exposure to alcohol, undetermined intent Y15 
Evidence of alcohol involvement determined by blood alcohol level Y90 
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Tuberculosis A15-A19, B90 Lonnroth et al 
2008 46 
Malignant neoplasm of lip, oral cavity and pharynx C00-C14 Tramacere et al 
2010 47 
Malignant neoplasm of oesophagus C15 Rota et al 2009 48 
Malignant neoplasm of colon and rectum C18-C21 Fedirko et al 2011 
49 
Malignant neoplasm of liver and intrahepatic bile ducts C22 Corrao et al 2004 
50 
Malignant neoplasm of larynx C32 Islami et al 2011 51 
Malignant neoplasm of breast C50 Key et al 2006 52 
Epilepsy and status epilepticus G40-G41 Samokhvalov et al 
2010 53 
Hypertensive diseases I10-I14 Taylor et al 2009 
54 
Cardiac arrhythmias I47-I48 Kodama et al 2011 
55 
Haemorrhagic and other non-ischaemic stroke I60-I62, I69.0-I69.2 Patra et al 2010 56 
Lower respiratory infections: pneumonia J09-J22, J85, P23 Samokhvalov et al 
2010 
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Cirrhosis of the liver (excluding alcoholic liver disease) K70 (excl. K70.0-K70.4, K70.9), K73-
K74 
Rehm et al 2010 
58
 
Acute and chronic pancreatitis K85-K86 excl. K85.2, K86.0 Irving et al 2009 59 
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) Diabetes mellitus (type II) E10-E14 Baliunas et al 
2009 
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Ischaemic heart disease I20-I25 Roerecke and 
Rehm 2010, 2012 
18,61 
Shield et al. 
2014
62
 
Ischaemic stroke I63-I67, I69.3 Patra et al 2010 56 
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Transport injuries (including road traffic accidents) V01-V98, Y85.0 Ridolfo & 
Stevenson, 1998
63
 Fall injuries W00-W19 
Exposure to mechanical forces (including machinery accidents) W20-W52 Single et al. 1996
64
 
Drowning W65-W74 
Other Unintentional Injuries W75-W99, X30-X33, X50-X58 
Accidental poisoning by exposure to noxious substances X40-X49 excl. X45 
Intentional self-harm X60-X84, Y87.0 excl. X65 
Assault X85-Y09, Y87.1 
Other intentional injuries Y35 
26 
 
 
Figure 2: Relative risk functions for chronic conditions partially attributable to alcohol
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3.5.1.1. Ischaemic heart disease and binge drinking 
Ischaemic heart disease (IHD) represents a special case in SAPM v.2.7 as it is the only condition 
where a literature-based risk function is adjusted to reflect additional evidence.  The source for the 
main risk functions suggests drinking up to approximately 8 units a day for males and 4 units a day 
for females is associated with a reduced risk of IHD relative to abstainers.18  However, an earlier 
study by the same authors finds this reduced risk is substantially attenuated or eliminated for those 
engaging in heavy episodic drinking (defined as consuming at least 7.5 units on a single day) at least 
once a month.61  As the present analysis does not consider frequency of heavy episodic drinking, this 
additional evidence is incorporated using a method employed by Shield et al.62 whereby the risk 
function for IHD is adjusted such that drinkers consuming more than 7.5 units per day on average 
(52.5 units per week) are assumed to (a) have an IHD relative risk of 1.0 when the original risk 
function is less than RR=1.0 and (b) follow the original risk function when RR≥1.0.  This limited 
adjustment means cardioprotective effects are likely to be overestimated within the model as many 
individuals with mean consumption less than 7.5 units per day are likely to be drinking this amount 
at least once a month.   
3.5.2. Relative risk functions derived from the alcohol-attributable fraction for partially-
attributable, acute conditions 
For partially-attributable acute conditions, risk functions are typically not available in published 
meta-analyses.  Therefore, an alternative method for deriving risk functions which links peak daily 
consumption to risk of these conditions is used.  This method is based around the alcohol 
attributable fraction (AAF) for the condition.   
In general, attributable fractions describe the proportion of cases of a condition which would not 
occur if the population were not subject to an exposure of interest (e.g. the proportion of lung 
cancer cases which would not occur if the population were entirely never smokers).  More 
specifically, attributable fractions are the difference between the overall average risk (or incidence 
rate) of a disease in the entire population and the average risk in those without the exposure factor 
under investigation, expressed as a fraction of the overall average risk.  For the present analyses, the 
AAF is used to describe the proportion of partially-attributable acute harms which would not occur if 
the population’s peak daily consumption was zero.   
The AAF can be calculated using the following formula: 
 Equation 1 
 
Where RRi is the relative risk due to exposure to alcohol at consumption state i, pi is the proportion 
of the population exposed to alcohol at consumption state i and n is the number of consumption 
states.  Thus the numerator is the excess expected cases of the condition due to alcohol exposure 
and the denominator is the total expected cases.   
AAFs for partially-attributable acute conditions in the UK have been recently calculated by Jones and 
Bellis.43  This evidence and Equation 1 are used to compute risk functions for these conditions.   
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Two assumptions are necessary to compute a relative risk function from an AAF.  First, assumptions 
regarding the functional form (e.g. linear, various curvilinear forms).  Linear functions were selected 
for the present analyses due to the lack of data on functional forms within the literature.  Second, 
assumptions are also required regarding any consumption threshold below which the relative risk is 
equal to that of abstainers.  An example of risk functions with and without threshold effects is shown 
in Figure 3.  For the present analysis, the commissioners (Public Health England) requested a risk 
function with no threshold effect be used to reflect evidence that, for motor vehicle accidents, there 
is increased risk relative to abstention at any level of consumption.65  In previous versions of SAPM, 
thresholds of four units for males and three units for females were selected and the rationale for 
this is described elsewhere.32  As described below, threshold effects normally included within SAPM 
were also removed for wholly-attributable acute and chronic conditions.  Sensitivity analyses 
investigating the impact of using the alternative specification where threshold effects are included 
are presented in Section 4.5.1 of the Results.   
 
  
Figure 3: Illustrative linear relative risk function for a partially attributable acute harm with 
and without a threshold effect of 4 units. 
 
3.5.3. Absolute risk functions for wholly-attributable acute conditions 
While it is possible to estimate relative risk functions for most conditions, it is impossible to derive 
such functions linking peak daily consumption to risk of wholly alcohol-attributable acute harms (i.e. 
those with an AAF of 100%).  This is because there is no reference group for the function to be 
relative to as abstainers, by definition, have zero risk of suffering wholly-attributable conditions.   
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Thus, an alternative approach is adopted whereby absolute risk functions are calculated for eight 
age and sex groups (male and female, ages: 16-24, 25-34, 35-54, 55+) based on the mortality rate or 
morbidity prevalence of the condition, the prevalence of different peak daily consumption levels and 
the population size of the age-sex group.  As with the relative risk functions derived in Section 3.5.2, 
assumptions are necessary regarding the functional form and peak daily consumption threshold 
above which risk starts to increase.  For consistency, the same linear form and lack of threshold 
effect was assumed and sensitivity analyses are used to examine the impact of modelling an 
alternative scenario where a threshold effect is included.   
3.5.4. Absolute risk functions for wholly-attributable chronic conditions 
Risk functions for wholly-attributable chronic conditions were calculated in the same way as for the 
acute equivalent with mean weekly consumption substituted for peak daily consumption.  As with 
acute conditions, an assumption of no threshold before risk starts to increase was made.     
3.6. Modelling procedure 
3.6.1. Modelling current drinking, zero drinking and points in-between 
To estimate the number of deaths (and hospitalisations) per annum which would accrue under 
different levels of alcohol consumption, a three step process is undertaken. 
First, the current levels of alcohol consumption and current levels of risk of mortality for each 
age/gender group are inputted to SAPM to derive the risk functions as described in Sections 3.5.2 
and 3.5.3.   If the model is then run with input consumption at current levels alongside these 
calibrated risk functions, it returns as a result the current number of deaths per annum in each age-
gender group, and for all males, all females, and the whole population aged 16+.  The resulting 
number of deaths can be thought of as being made up of five components: 
1. C1: Deaths for chronic alcohol-related conditions which are attributable to alcohol  (e.g. 
deaths from oral cancers caused by alcohol); 
2. C0: Deaths for chronic alcohol-related conditions which are not attributable to alcohol 
(e.g. deaths from oral cancers not caused by alcohol); 
3. A1: Deaths from acute alcohol-related conditions which are attributable to alcohol (e.g. 
deaths from injuries caused by alcohol); 
4. A0: Deaths from acute alcohol-related conditions which are not attributable to alcohol 
(e.g. deaths from injuries not caused by alcohol); 
5. OD: Other deaths from causes unrelated to alcohol (e.g. deaths from lung cancer). 
Second, an extreme what-if scenario where there is no drinking in the UK is then run in SAPM using 
the same risk functions.  This what-if analysis estimates mortality levels if every person in the UK 
were drinking zero units of alcohol per week and gives a resulting number of deaths that is lower 
than in the first step as there are no deaths due to alcohol.  The interpretation of the result of this 
model run is that it quantifies (C0+A0) the number of deaths in the 43 alcohol related conditions that 
are not currently caused by alcohol and (OD) deaths from other disease causes that are not related 
to alcohol at all, but has eliminated all of (C1 and A1) deaths in the 43 alcohol related conditions that 
are actually caused by alcohol.  The number of deaths in this second step is therefore C0+A0+OD.   
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Third, SAPM is then repeatedly rerun for a set of what-if analyses.  Each analysis obtains results for a 
scenario where every person in the UK is drinking at an exact specified level (e.g. all drinking one 
unit of alcohol per week, all drinking two units per week, etc.).  This enables graphs to be drawn with 
the specified level of drinking on the x-axis and the number of deaths per annum on the y-axis.   
3.6.2. What-if analyses separating effects for chronic and acute conditions and 
combining all alcohol-related conditions 
For the present analyses, three sets of risk curves were derived describing relationships between 
mean weekly consumption and chronic alcohol-related health conditions, peak daily consumption 
and acute alcohol-related health conditions and mean weekly consumption spread over one to 
seven days and all alcohol-related health conditions.  The processes for estimating mortality and 
morbidity risks associated with given consumption levels using SAPM is described below followed by 
a description of the process for converting mortality and morbidity point estimates into the required 
risk curves. 
Morbidity estimates are not produced using the Australian approach as the University of Sheffield do 
not hold the required data on all-cause morbidities.   Similarly, risk curves relating to the Australian 
approach (i.e. the proportion of all deaths attributable to alcohol) are not estimated when 
examining chronic or acute alcohol-related conditions separately.  This is because the risk estimates 
underpinning the curve are calculated as a proportion of the total annual number of deaths.  Using 
the terminology above, this would be:   
%𝐷𝑒𝑎𝑡ℎ𝑠 𝑤ℎ𝑖𝑐ℎ 𝑎𝑟𝑒 𝐶1 =
𝐶1
𝐶1 + 𝐶0 + 𝐴1 + 𝐴0 + 𝑂𝐷
 
Equation 2 
When examining chronic alcohol-related deaths, an estimate of the number of A1 deaths would be 
required and this can only be obtained by assuming a level of peak daily consumption in the 
population.  There is no sound basis for such an assumption under the hypothetical scenario that the 
population all has the same mean weekly consumption.  An alternative approach would be to 
calculate the proportion of deaths from chronic alcohol-related causes which are attributable to 
alcohol (i.e. the AAF for these deaths) which can be expressed as: 
%𝐷𝑒𝑎𝑡ℎ𝑠 𝑤ℎ𝑖𝑐ℎ 𝑎𝑟𝑒 𝐶1 =
𝐶1
𝐶1 + 𝐶0
 
Equation 3 
However, it was judged that this was a significant departure from the absolute risk focus which 
informs the Australian approach.  The same problem exists when examining risks for acute alcohol-
related conditions.  Consequently, the Australian approach is applied only when considering total 
mortality risk from all alcohol-related causes simultaneously.  This approach involves assuming a 
range of peak daily consumption levels and comparing the implied guideline across those levels.   
3.6.2.1. Mean weekly consumption and chronic alcohol-related health conditions 
Mean weekly consumption is set to be uniform across the population and the level of mortality and 
morbidity for chronic alcohol-related conditions are estimated using SAPM.  As there is no 
relationship in the C2H component of SAPM between peak daily consumption and chronic alcohol-
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related health conditions, peak daily consumption data are not considered.  The process is repeated 
for values of mean weekly consumption ranging from 0 to 49 units.   
Annual risks relative to abstainers of mortality and morbidity due to chronic alcohol-related 
conditions are estimated.   
3.6.2.2. Peak daily consumption and acute alcohol-related health conditions 
Peak daily consumption for the population is set to be uniform across the population and the level of 
mortality and morbidity for acute alcohol-related conditions is estimated using SAPM.  As there is no 
relationship in the C2H component of SAPM between mean weekly consumption and acute alcohol-
related conditions, mean weekly consumption data are not considered.  The process is repeated for 
values of peak daily consumption ranging from 0 to 49 units.  
Annual risks relative to abstainers of mortality and morbidity due to acute alcohol-related conditions 
are estimated.   
3.6.2.3. Mean weekly consumption distributed across one to seven days and all alcohol-
related health conditions.  
Mean weekly consumption for the population is set to be uniform across the population and the 
level of mortality and morbidity for all alcohol-related health conditions is estimated.  However, for 
each level of mean weekly consumption modelled, the analysis follows the Australian drinking 
guidelines review by exploring a range of alternative assumptions regarding how consumption is 
distributed across the week.8  Specifically, the scenarios modelled in SAPM assume that 
consumption is distributed evenly across 1, 2, 3, 4, 5, 6 or 7 days.  For example, a mean weekly 
consumption of 20 units would be modelled seven times with peak daily consumption set to 20, 10, 
6.7, 5, 4, 3.3 and 2.9 units.  Although a range of alternative distributions of consumption across 
drinking days are possible, the modelled options crucially include those with the highest and lowest 
peak daily consumption (i.e. all on one day and evenly distributed across seven days).  These 
extreme cases will provide estimates of the maximum and minimum levels of total alcohol-related 
health risk associated with a given mean weekly consumption.   
The process is repeated for values of mean weekly consumption ranging between 0 and 49 units per 
week.  
Annual risks relative to abstainers of mortality and morbidity due to alcohol-related conditions are 
estimated.  Also estimated for each level of consumption is the annual proportion of mortality for all 
causes which is attributable to alcohol.  
3.6.3. Converting mortality and morbidity estimates into risk curves 
Relative risk estimates are derived by comparing estimated mortality levels when the population 
drink at values above zero with estimated mortality levels when the population do not drink.  Risk 
curves describing the proportion of mortalities which are alcohol attributable and for the relevant 
conditions can be derived by comparing, for a given level of consumption, estimated mortality for 
alcohol-related causes with estimated total mortality in the population.  Similar processes can be 
used to derive morbidity estimates and separate estimates for males and females.   
In order to calculate the precise levels of consumption which correspond to the Canadian and 
Australian approaches (i.e. RR=1 and AR=1/100), fractional polynomials are fitted to the model 
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results66 using the Stata 1241 command fracpoly and the resulting polynomial equations are solved as 
required. These polynomials are also used directly in order to derive absolute risks of alcohol-
attributable mortality at different levels of consumption.  
3.7. Sensitivity analyses 
To assess the impact of alternative assumption, evidence and methodologies on the results, five 
sensitivity analyses are conducted which examine: 
 The effect of alternative assumptions regarding the threshold consumption level above 
which risks for acute alcohol-related harms begin to increase (see Section 3.5.2); 
 The effect of assuming alcohol consumption at any level does not reduce risks of any health 
condition; 
 The effect of modelling different time periods;  
 The effect of accounting for recent trends in cardiovascular mortality; 
 The effect of using alternative versions of the Canadian and Australian approaches. 
 
3.7.1. Sensitivity analysis 1: Assuming an alternative threshold for acute risks 
As described in Section 3.5.2, previous analyses using SAPM have included threshold effects within 
risk functions for acute conditions and wholly-attributable chronic conditions such that risk only 
begins to increase above a pre-specified consumption level.  At the request of the commissioners 
(Public Health England), this threshold effect was removed for the base case analysis meaning there 
is no threshold mean weekly or peak daily alcohol consumption level below which risks of acute 
alcohol-related mortality or morbidity are equivalent to that of abstainers.   
To test the impact of this revised assumption, a sensitivity analysis was conducted with the assumed 
thresholds used in previous version of SAPM reinstated.  These thresholds assume for acute 
conditions that risks are equivalent to abstainers when peak daily consumption is equal to or less 
than four units for males and three units for females.  For wholly-attributable chronic conditions, 
risks are assumed to be equivalent to abstainers when mean weekly consumption is equal to or less 
than two units for females and three units for males.   
3.7.2. Sensitivity analysis 2: Assuming alcohol consumption at any level does not reduce 
health risks 
Risk functions for the following conditions all include reduced mortality or morbidity risk relative to 
abstainers at some levels of mean weekly alcohol consumption for males and/or females (see Figure 
2): 
 Ischaemic heart disease 
 Ischaemic stroke 
 Haemorrhagic stroke  
 Hypertensive diseases 
 Type II diabetes 
These apparent protective effects are subject to considerable scientific debate and, therefore, the 
effect of removing them is examined by a sensitivity analysis setting relative risks at all consumption 
levels where RR<1 to RR=1.  Relative risks for consumption levels where RR≥1 are left unadjusted.  
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3.7.3. Sensitivity analysis 3: Modelling different time periods 
SAPM can model the effects of the population distribution of consumption on mortality and 
morbidity for a number of years specified by the user.  In the present analysis, the modelled period 
is a single year.  Running the model for a longer time period (e.g. 20 years) would alter the results.  
This is because the demographic structure of the population is based on ONS 2013 mid-year 
population estimates which are partly a product of the population’s current (and previous) alcohol 
consumption.  Within the present analysis, consumption is set to uniform levels for the whole 
population and over time the mortality consequences of drinking at these levels will gradually alter 
the demographic structure of the population with a greater extent of restructuring as the number of 
modelled years increases.  This demographic restructuring means there are different absolute 
mortalities and morbidities for each condition in each age-sex group over time meaning the 
population risk curves for mortality and morbidity for all alcohol-related conditions are also 
different.   
The effect of this is examined in a sensitivity analysis modelling a longer time period, specifically 10 
years. 
3.7.4. Sensitivity analysis 4: Exploring impact of trends in cardiovascular mortality 
Cardiovascular diseases (CVD) are one of the leading causes of death in the UK; however, mortality 
rates from these conditions has been falling consistently over the past 30 years and are forecast to 
continue to fall into the future.67 Alcohol is both a key risk factor for cardiovascular conditions and, 
at low consumption levels, may provide protective effects against these conditions.  Therefore, 
changes in mortality rates for cardiovascular conditions are likely to impact on the implied guideline 
thresholds derived from SAPM. 
To examine the potential effect of these changes in a sensitivity analysis, we update the baseline 
cardiovascular mortality rates used in the base case to those reported in the latest published figures 
for 2013 from England and Wales, Scotland and Northern Ireland.42,68,69  These show an overall 
reduction of just over 9% in cardiovascular deaths, although these changes vary between health 
conditions as shown in Table 5. 
Table 5: Changes in cardiovascular mortality rates from baseline years to 2013 
Condition 
% change in overall 
mortality 
Hypertension -17.2% 
Cardiac arrhythmias -5.4% 
Haemorrhagic and other non-ischaemic stroke -7.1% 
Ischaemic heart disease -13.5% 
Ischaemic stroke 6.8% 
All cardiovascular conditions -9.2% 
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3.7.5. Sensitivity analysis 5: Using alternative thresholds under the Canadian and 
Australian approach 
As noted in the Introduction, the Australian approach of setting the drinking guideline at the 
consumption level where 1% of all annual deaths are attributable to alcohol is somewhat arbitrary.  
Guidelines derived by applying thresholds of 0.5%, 1.5% and 2.0% of all annual deaths being 
attributable to alcohol are examined to assess the sensitivity of the implied guideline to alternative 
thresholds.   
Also examined is an alternative to the Canadian approach whereby the nadir of the risk curve (i.e. 
the consumption level associated with the largest risk reductions relative to abstainers) is used to 
derive a guideline threshold.   
3.8. Methodological differences compared to the Canadian and Australian 
analyses 
Although informed by the Canadian and Australian approaches, there are importance differences 
between the analyses undertaken in those countries and in the present report.  The key differences 
are listed below: 
 The present report takes account of frequency of consumption when applying the Canadian 
approach for total alcohol-attributable mortality.  This was not done in the Canadian 
analyses.  
 Evidence of protective effects are included in all analyses here except Sensitivity Analysis 2.  
In Australia, protective effects were excluded from the base case.   
 The alcohol-related health conditions modelled vary between each of the analyses.  This 
reflects a range of consideration including the scope of the analyses, evidence available at 
the time the work was conducted and the methodological decisions of the researchers.  The 
full lists of conditions modelled are included in each country’s report.6,8 
 SAPM and the Australian modelling both incorporate simultaneous analyses of both acute 
and chronic risks.  In Canada these two types of risk were analysed separately.  
 The Australian report discusses lifetime risks whereas here risks are referred to as annual 
risks.  However, where risks are averaged across the population, these are identical.   
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4. Results 
The results below are presented in five sections.  First, the baseline mortality and morbidity data for 
the population are presented to illustrate how health risks and alcohol-related health risks are 
distributed across the population.  This has important implications for the applicability of different 
risk thresholds to particular groups with the population.  Next, the results for mortality risks are 
presented and describe in turn (a) mean weekly consumption and its relationship to chronic alcohol-
related conditions, (b) peak daily consumption and its relationship to acute alcohol-related 
conditions and (c) mean weekly consumption distributed across one to seven days and its 
relationship to all alcohol-related conditions.  A summary of morbidity results are then presented 
followed by an analysis of mortality risk by age group which illustrates some of the conceptual and 
analytical challenges of considering age group-specific risk thresholds.  Finally the results of the 
sensitivity analyses are presented. 
4.1. Baseline mortality and morbidity 
4.1.1. Baseline mortality rates 
Table 6 shows the baseline annual mortality rates used in the model by age, sex and different 
causes.  This highlights four important differences in cause of death by age and sex.  
 
Table 6: Baseline annual mortality rates by age, sex and attribution 
Mortalities per 
100,000 
population 
16-24 25-34 35-54 55+ Total 
All 
M F M F M F M F M F 
Acute alcohol-
attributable
1 10.1 1.8 12.9 1.8 17.3 4.2 18.2 7.6 15.8 4.6 10.2 
Chronic alcohol-
attributable
1 0.5 0.2 3.7 2.6 24.1 16.2 53.9 21.3 27.0 13.2 20.1 
Total alcohol-
attributable 
10.6 2.1 16.6 4.4 41.4 20.4 72.1 28.9 42.8 17.8 30.3 
Total non-
alcohol 
attributable 
43.5 26.3 58.1 36.0 192.5 148.2 2,741.1 3,083.5 1,000.0 1,082.2 1,041.0 
% mortalities 
alcohol-
attributable 
19.6 7.3 22.2 10.9 17.7 12.1 2.6 0.9 4.1 1.6 2.8 
1
Acute and chronic refer to types of conditions listed in Table 4.  Chronic deaths are those assumed to be associated with mean weekly 
consumption over time and acute deaths are those assumed to be associated with a single drinking occasion.  
 
First, at all ages and for both acute and chronic conditions, alcohol-attributable mortality rates are 
higher for males than females.   
Second, alcohol-attributable mortality rates for both chronic and acute conditions increase 
substantially with age for both males and females.    
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Third, at age 16-24, alcohol-attributable deaths account for a large minority of all deaths and the 
proportion is greater for males than females (19.6% vs. 7.3%).  With increasing age, this proportion 
declines and the gap between males and females diminishes in absolute terms.  By age 55 and over 
the proportions are 2.6% for males and 0.9% for females.  This mainly reflects much greater risks of 
non-alcohol-attributable mortality for older age groups which are not present at younger ages.   
Finally, the balance of mortalities from acute vs. chronic conditions changes with age.  At age 16-24, 
mortalities from acute conditions dominate for both sexes and for males in particular.  Although the 
mortality rate for acute conditions increases with age, the rate for chronic conditions increases more 
sharply.  By age 35-54, there are more mortalities from chronic conditions than acute conditions for 
both sexes and the gap widens further among those aged 55 and over.   
4.1.2. Baseline morbidity rates 
Table 7 presents baseline annual morbidity data by age, sex and attribution.  Due to the data 
limitations discussed in Section 3.2.2, morbidity rates for other causes are not presented.  The 
patterns are similar to those identified for mortality with consistently higher alcohol-attributable 
morbidity rates for males and higher alcohol-attributable morbidity for acute conditions and lower 
morbidity for chronic conditions at younger ages.  
 
Table 7: Baseline annual morbidity rates by age, sex and attribution 
Morbidities
1
 per 
100,000 
population 
16-24 25-34 35-54 55+ Total 
All 
M F M F M F M F M F 
Acute alcohol-
attributable
2 683 456 642 331 848 453 781 323 2,129 1,218 3,347 
Chronic alcohol-
attributable
2 66 50 124 99 549 488 2,913 333 1,412 400 1,812 
Total alcohol-
attributable 
749 506 766 429 1,397 941 3,694 656 3,542 1,617 5,159 
1
Morbidity defined as person-specific hospital admissions.  
2
Acute and chronic refer to types of conditions listed in Table 4.  Chronic morbidities are those assumed to be associated 
with mean weekly consumption over time and acute morbidities are those assumed to be associated with a single 
drinking occasion.  
 
4.2. Mortality risks 
The mortality risk results are presented below.  In each case, fitted fractional polynomial curves are 
presented in the Figures and are used to derive implied guideline thresholds using the Canadian and, 
when considering all mortalities (Section 4.2.3), the Australian approach.   
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4.2.1. Mortality risks for chronic alcohol-related conditions 
Figure 4 presents the estimated relative risk curves relating mean weekly consumption to relative 
risk of mortality from chronic alcohol-related causes.  Curves for each gender are presented.   The 
implied guideline threshold for males and females using the Canadian approaches is highlighted and 
summarised in Table 8 along with the relative risk associated with this consumption level.   
Both of the risk curves are j-shaped, primarily as a result of the association between reduced 
cardiovascular risk and moderate levels of alcohol consumption.  The nadir of the curve (i.e. the 
point of lowest risk) is  0.5 units greater per week for females compared to males (3.9 vs 3.4) and the 
reduction in risk relative to abstainers at this point is greater for females (RR=0.92 vs. 0.97).   
However, above the nadir, risk increases at a steeper rate for females than males.  This suggests that 
any overall protective effects afforded by moderate drinking are greater for women and peak at very 
low consumption levels (i.e. less than one unit per day).  
The guideline threshold which would be selected using the Canadian approach (i.e. where female 
drinkers have higher risks than female abstainers) is 14.1 units per week.  The equivalent threshold 
for males is lower at 12.5 units per week.  Above this threshold the male and female curves continue 
to diverge due to the steeper risk increases for females.   
Table 8: Implied guideline mean weekly consumption thresholds for chronic alcohol-related 
mortality 
 Guideline threshold in units per week 
Threshold  Males Females Population 
Canadian: RR=1.0 12.5 14.1 13.7 
Lowest possible risk (nadir of curve) 3.4 3.9 3.8 
Relative risk at the nadir 0.97 0.92 0.94 
 
 
Figure 4: Relative risk of death due to chronic alcohol-related causes by mean weekly 
consumption level 
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4.2.2. Mortality risks for acute alcohol-related conditions 
Figure 5 presents the estimated relative risk curves relating peak daily consumption and relative risk 
of mortality from acute alcohol-related causes.  As with chronic conditions, curves are presented for 
both genders.  As there is no evidence of reduced risk relative to abstainers for any consumption 
level, the Canadian approach provides no means of deriving a guideline threshold (or, under a 
different interpretation, implies that the guideline threshold should be zero).   
The risk curve for males is steeper than females meaning risk relative to abstainers increases with 
rising peak daily consumption at a faster rate for males than females.  Relative risks are also greater 
than those observed in the graph for chronic alcohol-related conditions.  For example, the male 
relative risk for acute alcohol-related mortality relative to abstainers is 2.2 for a peak daily 
consumption of 10 units whereas the relative risk of mortality for chronic alcohol-related conditions 
when consuming 49 units per week is 1.4.     
These results suggest mortality risks for acute alcohol-related conditions are likely to notably 
influence overall alcohol-related mortality risks where drinking patterns include heavy drinking and 
that this influence will be greater for males than females. 
 
Figure 5: Relative risk of death due to acute alcohol-related causes by peak daily 
consumption level 
 
  
0
1
2
3
4
5
6
7
8
0 10 20 30 40 50
R
e
la
ti
ve
 r
is
k 
o
f 
d
e
at
h
 d
u
e
 t
o
 a
cu
te
 
al
co
h
o
l-
re
la
te
d
 c
au
se
s 
Peak day consumption (units) 
Male
Female
39 
 
4.2.3. Mortality risks for all alcohol-related conditions 
Figure 6 and Figure 7 present the male and female estimated relative risk curves relating mean 
weekly consumption spread across one to seven days to total alcohol-related mortality risk. Figure 8 
and Figure 9 present the equivalent estimated risk curves for the proportion of all deaths which are 
alcohol attributable.  The Canadian and Australian approaches provide no specific guidance for 
selecting a guideline threshold from among these curves; however, the minimum (units consumed 
all on one day) and maximum (units evenly spaced across seven days) guideline thresholds are 
highlighted in each figure and thresholds for each scenario are summarised in Table 9. 
These curves are composites of the chronic and acute risks and the results reflect this.  For example, 
risk curves are steeper when the same volume of alcohol is consumed on fewer days.  This reflects 
the increased risk of acute mortality associated with increased intoxication on drinking days.  
Similarly, the steeper acute risk curves for males (see Figure 5) and the greater incidence of acute 
alcohol-related mortality for males (see Table 6) mean the seven curves in each of Figure 6 to Figure 
9 are more affected by number of drinking days for males than females.   
The effect of number of drinking days on the male curves has important impacts on the j-curve and 
therefore the implied guideline thresholds.   
Figure 6 shows that, for males, the nadir of the curve is reached at 1.2 units per week if consumption 
occurs on a single day but 2.4 units per week if the individual drinks every day.  The maximum 
reduction in risk relative to abstainers is, however, small in both cases (RR=0.99 in both cases) 
demonstrating that any cardioprotective from moderate drinking have little impact on overall risks 
for males and particularly males whose drinking patterns include episodes of heavy drinking.  The 
implied male guideline under the Canadian approach is also sharply different across the seven 
curves, being 3.4 units per week if alcohol is consumed once a week and 9.8 units per week if alcohol 
is consumed every day.   
For females, the relative risk results are less affected by the number of drinking days reflecting the 
reduced importance of acute risks.  The nadir of the j-curve is reached at 2.8 and 3.4 units per week 
for drinking once a week and drinking daily respectively and the corresponding maximum reductions 
in risk relative to abstainers are RR=0.98 and RR=0.97 respectively.  Although greater than observed 
for males, these risk reductions remain modest and peak at very low levels of alcohol consumption, 
suggesting again that the importance of any cardioprotective effects of alcohol at the population 
level should not be over-emphasised when considered in the context of all other risks.  The implied 
female mean weekly consumption guidelines using the Canadian approach are 10.0 units per week if 
alcohol is consumed once a week and 13.6 units per week if alcohol is consumed every day. 
Under the Australian approach, the implied guidelines for both males and females are higher 
reflecting a definition of low risk which is necessarily above that used in the Canadian approach.  For 
males drinking once a week and drinking daily the implied guideline threshold would be 6.0 and 14.1 
units per week and the equivalent implied guidelines for females would be 12.0 and 15.7 units per 
week.   
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Figure 6: Male relative risk of death from alcohol-related causes by mean weekly 
consumption and number of drinking days 
 
Figure 7: Female relative risk of death from alcohol-related causes by mean weekly 
consumption and number of drinking days 
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Figure 8: Male proportion of deaths which are alcohol-attributable by mean weekly 
consumption and number of drinking days 
 
Figure 9: Female proportion of deaths which are alcohol-attributable by mean weekly 
consumption and number of drinking days 
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Table 9: Implied guideline for mean weekly consumption for total alcohol-related mortality by 
number of drinking days per week 
  Units per week 
Threshold  
Drinking 
days per 
week 
Males Females 
Canadian: RR=1.0 
1 3.4 10.0 
2 5.8 12.0 
3 7.4 12.8 
4 8.2 13.2 
5 8.9 13.4 
6 9.4 13.6 
7 9.8 13.6 
Australian: Proportion=1% 
1 6.0 12.0 
2 9.4 14.0 
3 11.3 14.8 
4 12.3 15.2 
5 13.1 15.4 
6 13.7 15.6 
7 14.1 15.7 
 
4.2.3.1. Absolute lifetime alcohol-attributable mortality risk 
The absolute lifetime risk of alcohol-attributable mortality for males and females drinking at 
different quantities and frequencies is shown in Table 10 and Table 11.  For males drinking 21 units 
per week across five drinking days (roughly equivalent to the current UK guidelines), absolute 
mortality lifetime risk is 0.03 and for females drinking 14 units per week across five drinking days 
(again roughly equivalent to the current UK guidelines), absolutealcohol-attributable mortality risk is 
0.003 – ten times lower than males.   
Table 10: Absolute lifetime risk of male alcohol-attributable mortality by consumption 
frequency and quantity 
Mean 
consumption  
(units/week) 
Drinking days per week 
7 6 5 4 3 2 1 
7 -0.0052 -0.0047 -0.0039 -0.0027 -0.0012 0.0027 0.0142 
14 0.0095 0.0106 0.0121 0.0144 0.0178 0.0252 0.0465 
21 0.0285 0.0300 0.0322 0.0355 0.0409 0.0514 0.0814 
28 0.0511 0.0531 0.0558 0.0599 0.0670 0.0802 0.1178 
35 0.0773 0.0796 0.0829 0.0877 0.0960 0.1114 0.1550 
42 0.1070 0.1097 0.1133 0.1187 0.1277 0.1449 0.1928 
49 0.1403 0.1431 0.1471 0.1529 0.1621 0.1806 0.2312 
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Table 11: Absolute lifetime risk of female alcohol-attributable mortality by consumption 
frequency and quantity 
Mean 
consumption 
(units/week) 
Drinking days per week 
7 6 5 4 3 2 1 
7 -0.0231 -0.0228 -0.0224 -0.0218 -0.0208 -0.0188 -0.0130 
14 0.0018 0.0023 0.0031 0.0043 0.0061 0.0099 0.0205 
21 0.0367 0.0374 0.0384 0.0400 0.0425 0.0476 0.0625 
28 0.0776 0.0785 0.0797 0.0816 0.0846 0.0907 0.1089 
35 0.1230 0.1240 0.1254 0.1275 0.1309 0.1377 0.1582 
42 0.1720 0.1731 0.1746 0.1768 0.1806 0.1880 0.2096 
49 0.2239 0.2251 0.2267 0.2290 0.2330 0.2408 0.2626 
 
Black text, green background - overall protective effect 
Red text, light orange background - overall lifetime risk less than 1 in 100 
Black text, orange background - overall lifetime risk at least 1 in 100, but below 1 in 10 
White text, red background - overall lifetime risk at least 1 in 10 
 
4.3. Morbidity risks 
Morbidity results using the Canadian approach are presented for the relationship between mean 
weekly consumption and chronic alcohol-related conditions and between peak daily consumption 
and acute alcohol-related conditions.  Due to the data limitations discussed in Section 3.2.2, no 
results are presented for total morbidity or using the Australian approach.  As with mortality, fitted 
fractional polynomial curves are shown in the figures and implied guideline thresholds are shown in 
the tables.   
4.3.1. Morbidity risks for chronic alcohol-related conditions 
Figure 10 shows the relative risk of chronic alcohol-related morbidity (defined as person-specific 
admission to hospital for chronic alcohol-related conditions) by mean weekly alcohol consumption.  
Curves are shown for both genders and the implied guideline threshold using the Canadian approach 
is highlighted and summarised in Table 12 along with information on the nadir of the curve.   
The risk curves are markedly different for males and females.  For males, there is no j-curve, with the 
relative risk for those who consume alcohol relative to abstainers equalling 1.0 at 0 units per week, 
and rising thereafter.  The absence of a j-curve presents a problem for using the Canadian approach 
to derive a guideline threshold as it implies either the guideline should be set at zero units per week 
or that no threshold can be derived.   
A j-curve is observed for females although the nadir is again at a very low consumption level of 2.5 
units per week.  However, the relative risk estimate associated with the nadir is 0.80, implying a 
meaningful morbidity risk reduction relative to abstainers. Following the nadir, the female curve is 
steeper than the male curve implying a faster rate of increase in risk with rising consumption.  The 
implied guideline threshold for females using the Canadian approach is 16.6 units per week. Above 
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24.8 units per week, relative risks for females are greater than for males for chronic alcohol-related 
causes.  
 
Figure 10: Relative risk of chronic alcohol-related morbidity by mean weekly consumption 
 
Table 12: Implied guideline mean weekly consumption thresholds for chronic alcohol-related 
morbidity 
 Guideline threshold in units per week 
Threshold  Males Females Population 
Canadian: RR=1.0 0 16.6 12.9 
Lowest possible risk (nadir of curve) 0 2.5 2.3 
Relative risk at the nadir 1.00 0.80 0.90 
 
4.3.2. Morbidity risks for acute alcohol-related conditions 
Figure 11 shows the estimated relative risk of acute alcohol-related morbidity by peak daily 
consumption for males and females.  As with the equivalent mortality graph, there is no j-curve for 
acute alcohol-related conditions and, therefore, the Canadian approach cannot be used to derive a 
drinking guideline.   
Acute morbidity risk increases more rapidly for males than females although the difference is 
smaller than for mortality risk (see Figure 5).  As with mortality, the risk estimates are sufficiently 
large that they can be expected to influence the overall morbidity risk, attenuating observed risk 
reductions relative to abstainers at low levels of consumption and making risk estimate sensitive to 
how many days mean weekly consumption is distributed across.  This is particularly the case for 
males who have higher baseline rates of acute alcohol-related morbidity,  
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Figure 11: Relative risk of acute alcohol-related morbidity by peak daily consumption 
4.4. Analysis of variation in risk by age 
Figure 12 to Figure 15 shows alcohol-related mortality risks by mean weekly consumption but 
separated by gender, age and the extremes of number of drinking days (i.e. drinking once a week or 
drinking daily).  When interpreting these figures, it should be remembered that SAPM estimates risks 
within each age group and not risks experienced by age groups across their whole life course.  
Therefore, the mortality risks for 18-24 year olds are not lifetime mortality risks starting from age 18-
24 but mortality risks while aged 18-24.  These figures illustrate several important points regarding 
age-related risks. 
First, implied guideline thresholds differ starkly depending on the age group under examination.  
This is largely a result of the very different risks to which each group is subject.  In short, younger age 
groups have high risk of acute alcohol-related mortality but very low risk of chronic alcohol-related 
mortality.  Older age groups have much higher risk of mortality for chronic conditions but similar 
acute condition mortality risk (see Table 6).  As a result, the risk curves for younger age groups are 
strongly influenced by acute risks whereas the risk curves for older age groups are more influenced 
by chronic risks.  Two features of the acute risk curve are salient: (a) there is no evidence of reduced 
mortality risk for acute alcohol-related conditions and (b) it is linear and has no threshold effect 
meaning risk increases consistently across all levels of consumption including very low levels.  As a 
results of these points, the Canadian approach to deriving guideline thresholds gives mean weekly 
consumption thresholds close to zero for younger age groups.  Similarly, the low overall mortality 
risk for younger age groups means a substantial proportion of deaths in this group are alcohol 
attributable.  Consequently, the Australian approach also implies a drinking guideline close to zero.  
Second, it is clear from all of the figures that reduced risks from moderate drinking among males and 
females aged under 55 are negligible or non-existent reflecting the low risk of cardiovascular disease 
in these groups.  For males aged 55 and over, these reduced risks are also very small and correspond 
to very low levels of consumption.  For females aged 55 and over, reduced risks are larger; however, 
the greatest risk reductions again correspond to low levels of mean weekly alcohol consumption 
(approximately five units per week).   
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Overall, these points demonstrate that the population-level risk curves reflect not only variations in 
degrees of risk across age groups but also substantial variation in the nature of risks to which 
different aged drinkers are exposed.  As these different risks have very different relationships to 
alcohol consumption (e.g. linear, j-shaped, curvilinear), this means a highly heterogeneous set of 
age-specific risks curves are being averaged to produce the population-level curve.  Neither the 
Australian nor Canadian approaches cope well with this heterogeneity when the approaches are 
applied to attempt to derive age-specific lower risk drinking guidelines.  
 
Figure 12: Male relative risk of alcohol-related mortality by mean weekly consumption, 
number of drinking days and age 
 
Figure 13: Female relative risk of alcohol-related mortality by mean weekly consumption, 
number of drinking days and age 
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Figure 14: Male proportion of deaths attributable to alcohol by mean weekly consumption, 
number of drinking days and age 
 
 
Figure 15: Female proportion of deaths attributable to alcohol by mean weekly consumption, 
number of drinking days and age 
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4.5. Sensitivity analyses 
Sensitivity analyses are presented in two sections: analyses of key assumptions and analyses of 
alternative thresholds for deriving implied guidelines.  
4.5.1. Analyses of key assumptions 
Four sets of sensitivity analyses were undertaken to understand the extent to which the results are 
affected by key assumptions.  The sensitivity analyses examined: 
 SA1: The impact of assuming a threshold effect in the function relating peak daily 
consumption to risk for acute alcohol-related conditions.  The modelled threshold assumed 
risk equivalent to abstainers up to three units for females and four units for males.70 
 SA2: The impact of assuming no protective effects for cardiovascular conditions.  Where 
consumption levels are associated with reduced risk relative to abstainers, the risk function 
is adjusted so risk is equal to abstainers (i.e. Relative Risk = 1.0).   
 SA3: The impact of modelling a longer time period; namely 10 years.  This allows shifts in the 
demographic structure of the population to occur following reduced premature mortality. 
 SA4: The impact of accounting for recent trends in mortality rates from cardiovascular 
conditions, using the most recent available figures from 2013. 
The implied guideline thresholds for mortality under each sensitivity analysis and the base case are 
presented in Table 13.  The results show that assumptions regarding the presence of absence of 
threshold effects have a substantial impact on the implied guidelines, particularly for males and 
when using the Canadian approach. Implied guideline thresholds for men are approximately twice as 
high as in the base case when using the Canadian approach, and around 60% higher under the 
Australian approach. The thresholds for women are 10-15% higher under either approach. 
Modelling a ten year period to allow the demographic structure of the population to change in 
response to new drinking behaviours and accounting for recent trends in cardiovascular mortality 
both have moderate impacts on the implied guidelines.  In general modelling a longer time period 
leads to slightly higher implied guideline thresholds, while accounting for reductions in 
cardiovascular death rates leads to slightly lower implied guidelines thresholds.  In the latter case, 
this is because the impact of cardioprotective effects on overall death rates is reduced. To illustrate 
the scale of these differences, the implied guideline threshold for males drinking daily using the 
Canadian approach is 9.8 units per week in the base case, 10.2 units per week when modelling a ten 
year time period and 9.5 units per week when modelling lower baseline CVD mortality rates.    
Crucially, assuming no protective effects substantially lowers the implied guideline.  The Canadian 
approach relies on the presence of protective effects so no guideline is derived; however, under the 
Australian approach the implied guideline threshold is below four units per week in all instances.  
This highlights that although observed protective effects are small, they exert a strong influence on 
overall risk estimates.    
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Table 13: Implied guideline for mean weekly consumption under different sensitivity analyses 
    Units per week 
    Males Females 
Threshold 
Drinking 
days per 
week 
Base 
case 
SA1: 
Threshold 
effect 
SA2: No 
protective 
SA3: 
10 
yrs 
SA4: 
CVD 
risks 
Base 
case 
SA1: 
Threshold 
effect 
SA2: No 
protective 
SA3: 
10 yrs 
SA4: 
CVD 
risks 
Canadian 
RR=1.0 
1 3.4 6.4 - 3.5 3.6 10.0 9.7 - 10.3 6.8 
2 5.8 12.4 - 6.1 6.0 12.0 13.1 - 12.1 8.5 
3 7.4 15.8 - 7.6 7.4 12.8 14.6 - 12.6 9.2 
4 8.2 17.7 - 8.6 8.2 13.2 15.1 - 13.0 9.6 
5 8.9 18.7 - 9.3 8.7 13.4 15.4 - 13.2 9.8 
6 9.4 19.3 - 9.8 9.2 13.6 15.6 - 13.4 10.0 
7 9.8 19.2 - 10.2 9.5 13.6 15.8 - 13.5 10.1 
Australian 
Proportion
=1% 
1 6.0 8.2 1.5 6.4 6.0 12.0 11.2 2.3 12.4 9.2 
2 9.4 14.9 2.1 10.0 9.3 14.0 14.6 2.8 14.4 11.1 
3 11.3 18.5 2.4 11.8 10.9 14.8 16.2 3.1 15.1 11.9 
4 12.3 20.1 2.6 13.0 11.9 15.2 16.9 3.2 15.5 12.3 
5 13.1 21.5 2.7 13.8 12.6 15.4 17.2 3.3 15.8 12.6 
6 13.7 22.1 2.8 14.6 13.2 15.6 17.5 3.3 15.9 12.8 
7 14.1 22.2 2.9 15.1 13.5 15.7 17.6 3.4 16.0 12.9 
 
4.5.2. Analysis of alternative thresholds 
Both the Canadian and Australian approach could be applied differently to derive guideline 
thresholds.  Under the Canadian approach, instead of defining low risk as the consumption level at 
which risks are equal to those of abstainers, an alternative application is to define low risk as the 
consumption level at which the greatest risk reduction is seen relative to abstainers (i.e. the nadir of 
the curve).  Under the Australian approach, alternative proportions of mortalities or morbidities 
which are alcohol-attributable could be used (e.g. 2.0% instead of 1.0% of deaths being alcohol-
attributable).   
Table 14 presents estimated guideline thresholds for mortality comparing the base case Canadian 
results and results if the nadir of the curve is used instead.  By definition the implied thresholds are 
lower under the sensitivity analysis than in the base case.  Maximum risk reductions typically occur 
at very low levels of consumption and do not increase substantially if drinking is spread over a larger 
number of days.   For males, the nadir of the curve is estimated to occur at 1.2 units per week if 
drinking once per week and 4.3 units per week if drinking daily.  For females, the equivalent 
estimates are 3.2 units and 4.3 units.  
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Table 14: Estimated guideline thresholds for mortality under different applications of the 
Canadian approach (SA5) 
  Units per week 
  Males Females 
Threshold  
Drinking 
days per 
week 
Base case 
RR=1.0 
Sensitivity analysis 
Nadir of curve 
Base case 
Sensitivity analysis 
Nadir of curve 
Canadian 
1 3.4 1.2 10.0 2.8 
2 5.8 1.7 12.0 3.2 
3 7.4 2.1 12.8 3.4 
4 8.2 2.0 13.2 3.5 
5 8.9 2.2 13.4 3.6 
6 9.4 2.3 13.6 3.6 
7 9.8 2.4 13.6 3.4 
 
Table 15 compares alternative estimated guideline thresholds using the Australian approach.  
Thresholds are derived which correspond to consumption levels when the proportion of deaths 
which are alcohol-attributable is 0.5%, 1.0%, 1.5% and 2.0%.    
The use of these alternative cut-off points has a moderate impact on the estimated guideline 
threshold.  For males, the threshold varies between 4.7 and 8.3 units per week if drinking once per 
week and between 12.0 and 18.0 units per week if drinking daily.   Similar differences are seen for 
females where the threshold varies between 11.0 and 13.9 units per week if drinking once per week 
and 14.7 and 17.8 units per week if drinking daily.   
Table 15: Estimated guideline thresholds for mortality under different applications of the 
Australian approach 
  Units per week 
  Males Females 
Threshold  
Drinking 
days per 
week 
SA 
0.5% 
Base 
case 
1.0% 
SA 
1.5% 
SA 
2.0% 
SA 
0.5% 
Base 
case 
1.0% 
SA 
1.5% 
SA 
2.0% 
Australian 
1 4.7 6.0 7.1 8.3 11.0 12.0 12.9 13.9 
2 7.7 9.4 10.9 12.4 12.9 14.0 15.0 16.0 
3 9.5 11.3 13.0 14.7 13.7 14.8 15.8 16.8 
4 10.3 12.3 14.2 15.9 14.1 15.2 16.2 17.2 
5 11.1 13.1 15.0 16.8 14.4 15.4 16.5 17.5 
6 11.6 13.7 15.7 17.5 14.5 15.6 16.7 17.7 
7 12.0 14.1 16.1 18.0 14.7 15.7 16.8 17.8 
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5. Discussion 
5.1. Summary of results 
Table 16 summarises the implied guideline consumption thresholds derived using different 
approaches.  Thresholds are presented as both units per week and units per day as the latter more 
clearly illustrates how the number of days on which alcohol is consumed affects the estimated 
guideline threshold using either the Canadian or Australian approaches.  These risk estimates and 
the sensitivity analyses point to five key findings described below.   
Table 16: Implied guideline consumption thresholds using different approaches 
  Units per week Units per day 
Threshold  
Drinking 
days per 
week 
Males Females Males Females 
Canadian: RR=1.0 
1 3.4 10.0 3.4 10.0 
2 5.8 12.0 2.9 6.0 
3 7.4 12.8 2.5 4.3 
4 8.2 13.2 2.1 3.3 
5 8.9 13.4 1.8 2.7 
6 9.4 13.6 1.6 2.3 
7 9.8 13.6 1.4 1.9 
Australian: Proportion=1% 
1 6.0 12.0 6.0 12.0 
2 9.4 14.0 4.7 7.0 
3 11.3 14.8 3.8 4.9 
4 12.3 15.2 3.1 3.8 
5 13.1 15.4 2.6 3.1 
6 13.7 15.6 2.3 2.6 
7 14.1 15.7 2.0 2.2 
 
First, using the Canadian approach, the implied drinking guideline for males is between 1.4 units per 
day if drinking every day and 3.4 units per day if drinking once per week. The implied drinking 
guideline for females is 1.9 units per day if drinking every day (0.5 units greater than the male figure) 
and 10.0 units per day if drinking only once per week.  The estimate for drinking once per week is 
much higher for females than males (10.0 units per day vs. 3.4 units per day) because the absolute 
risk of acute injury, even at high consumption levels, is much lower for females than males.  Thus the 
implied female differs from the male threshold by being more strongly influenced by chronic risks, 
which are associated with mean weekly consumption, and less affected by acute risks, which are 
influenced by consumption frequency.  More generally, it should be noted that acute risks are 
related to drinking on a single occasion and are partly attributable to factors including the drinking 
context (e.g. at home or in a bar) and the characteristics of the drinker.  Thus the estimated 
threshold of 10.0 units if drinking once per week reflects the drinking contexts and drinker 
characteristics of an average female in the population rather than those of specific female drinkers 
at which any guideline may be targeted.   
Second, the implied thresholds using the Australian approach are all marginally higher than those 
implied using the Canadian approach.  Using the Australian approach, the implied drinking guideline 
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for males is between 2.0 units per day if drinking every day and 6.0 units per day if drinking once per 
week.  The implied drinking guideline for females is 2.2 units per day if drinking every day and 12.0 
units per day if drinking once per week (again much higher than the equivalent estimate for males).   
Third, the above results all consider the male or female population as a group and use average 
estimated risks from ages 18 through to 89.  Risk curves actually vary substantially by age and there 
are particular differences by age in the balance of acute vs. chronic risks and the underlying absolute 
level of health risk.  These differences create problems for the Canadian and Australian approaches 
and suggests they are not well-suited to deriving age group-specific guideline thresholds. For 
example, younger age groups (i.e. 18-24, 25-34) have very low absolute mortality risk and 
particularly low chronic disease mortality risk, including for cardiovascular diseases.  This means 
potential cardioprotective effects have only a minor influence when calculating this age group’s 
average mortality risk across all alcohol-related conditions.  Instead, the average risk curve is 
dominated by the acute risks which account for most alcohol-related mortality at younger ages.  
These acute risks increase linearly from zero and thus outweigh the small contribution of 
cardioprotective effects except at very low consumption levels.  Consequently, any guideline 
threshold derived from the under-35s average risk curve using the Canadian approach would be 
correspondingly very low.  Similarly, under the Australian approach, the very low chronic disease 
mortality risk at younger ages means acute deaths, including alcohol-attributable acute deaths, 
account for a large percentage of total deaths in this age group.  An age-specific guideline threshold 
derived using the Australian approach (based on the consumption level where 1% of deaths are 
alcohol-attributable) would, therefore, also be very low.  
If the Guideline Development Guide wished to derive age-specific guideline threshold, then one 
alternative would be to consider methods based around each age group’s absolute annual risk of 
mortality.  This may draw on Spiegelhalter’s ‘Micromorts’ and ‘Microlifes’ approaches;71 however, 
the appropriate method for deriving a guideline threshold under such an approach is unclear.  The 
Australian 1 in 100 mortality risk could be adapted, although it is questionable whether the 
conceptual rationale underpinning this definition of acceptable lifetime risk can be considered 
equally valid for annual risk and for risk within all age groups.   
Fourth, associations between reduced mortality risks for cardiovascular disease and lower levels of 
alcohol consumption have only limited relevance for selecting population-level lower risk drinking 
guidelines.  The following points inform this conclusion:  
 Although reduced alcohol-attributable mortality risks at lower consumption levels remain 
after accounting for risks from other alcohol-related conditions where there is no evidence 
of protective effects, the level of risk reduction relative to abstainers is low.  The lowest 
relative risk of mortality compared to abstainers is 0.97 for females and 0.99 for males.  This 
risk reduction is associated with very low levels of consumption, namely 2.4 units per week 
for males drinking daily and 3.4 units per week for females drinking daily (see Table 14).  
 The Canadian approach derives a guideline threshold from the consumption level where 
there are no further reduced alcohol-attributable mortality risks. The analyses presented 
here suggest very small risk reductions for alcohol-related mortality persist up to 9.8 units 
per week for males drinking daily and 13.6 units per week for females drinking daily (see  
Figure 6 and Figure 7). 
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 Independent of alcohol consumption, people of each age and sex are at a different level of 
baseline risk for mortality from any cause and from each specific alcohol-related cause.  This 
means risk reductions related to cardiovascular disease are of different importance to each 
demographic group’s overall mortality risk.  Analysis of variation in alcohol-related risk by 
age suggests that cardioprotective effects are only sufficient to provide substantial risk 
reductions from low levels of drinking for females aged over 55 (see Figure 15).  For other 
groups, risk reductions for cardiovascular conditions are either largely or wholly outweighed 
by risk increases for other conditions. 
 Strong concerns over the robustness of the evidence base for cardioprotective effects mean 
that, even for older females, mortality risk reductions from moderate alcohol consumption 
may be minimal or absent.  
Fifth, the sensitivity analyses suggest the results are sensitive to alternative assumptions. For most 
sensitivity analyses (e.g. modelling a ten year time period, assuming lower CVD mortality rates, 
varying the threshold within the Australian approach) the size of variation from the base case in 
implied guideline thresholds is of the order of three units per week.  However, for other sensitivity 
analyses (e.g. reintroducing threshold effects used in previous versions of SAPM, assuming no 
cardioprotective effects from moderate alcohol consumption) the variation in results from the base 
case are larger and of the order of ten units per week.  These results suggest the base case should 
not be accepted uncritically as the implied guideline thresholds are sensitive to alternative 
assumptions and baseline data and there are not strong arguments for preferring the base case 
specifications over those used in the sensitivity analyses.  In particular the strong influence of 
assumptions regarding the veracity of observed cardioprotective effects is demonstrated.  Section 
5.4.1.2 of this report discusses the scientific debate regarding whether observed associations 
between moderate drinking and reduced cardiovascular mortality risk reflect a causal relationship 
and depending on one’s position on this debate, the implied guideline thresholds in the base case 
should be interpreted with particular caution.   
5.1.1. Results for single occasion drinking and acute risks 
As with the Canadian and Australian approaches on which it draws, this report provides no clear 
basis for selecting a single occasion drinking guideline.  This is because the Canadian approach relies 
on a j-curve which is not present when considering risks associated with an individual occasion of 
drinking.  Similarly, the Australian approach relies on modelling (in the present case using SAPM) 
which combines multiple heterogeneous occasions into an annual risk of alcohol-related mortality 
which can be compared to annual mortality risk from other occasions.   
To resolve this problem, the Guideline Development Group may consider that one motivation for 
having a single occasion threshold is that drinkers may not spread their consumption evenly across 
the week.  Thus drinkers may consume a large proportion of the mean consumption guideline on 
one or two occasions, increasing their acute risk.  In the context of this motivation, considering Table 
16 alongside information on the drinking patterns of those at greatest risk of acute harms may 
inform the selection of a single occasion guideline.  For example, if the groups at greatest risk of 
acute harms typically drink twice per week, the Australian approach would suggest a single occasion 
guideline of the order of 5 units for males and 7 units for females (while bearing in mind SAPM 
assumes equal consumption on each occasion).    
54 
 
For clarity, this approach does not permit a guideline to be straightforwardly extracted from the 
analyses presented above.  Instead, it relies on the Guideline Development Group considering and 
balancing the information in Table 16 and evidence on the typical drinking patterns of those at 
whom a single occasion guideline would be aimed.  The Group may also wish to factor into these 
considerations alternative literature-based evidence which speaks more directly to the risks of single 
occasion consumption.  Examples of this literature can be seen in the reports of the Canadian and 
Australian Guideline Development Groups and a more recent report by the RARHA project.6,8,72   
5.2. Comparison with previous analyses and guidelines 
In the base case, the implied guideline thresholds are lower than those in the current UK lower risk 
drinking guidelines and the guidelines which resulted from the Canadian and Australian reviews.  
The current UK guidelines are daily guidelines and recommend not drinking every day.  Assuming a 
maximum of five drinking days per week, the current UK guidelines imply maximum limits of 20 units 
per week for males and 15 units per week for females.  The Canadian and Australian mean weekly 
guideline levels equate to approximately 25 and 17 units per week for males and 17 units per week 
in both countries for females.   Assuming drinkers consume alcohol between three and five times a 
week, the implied weekly guidelines in this report vary between 7 and 13 units per week for males 
and 13 and 15 units per week for females.   
The current Australian guidelines give the same consumption threshold for both males and females, 
reflecting their Guideline Development Group’s conclusion that alcohol-attributable mortality risks 
do not significantly differ at the consumption levels of interest.  Although the UK Guideline 
Development Group may wish to take further evidence into account, Table 16 points toward a 
similar conclusion for males and females drinking on four or more days per week in the UK, although 
implied guidelines for females are slightly higher than males.   
Methodological differences between the analyses in each country should be borne in mind when 
comparing implied guidelines.  A key difference between the present analysis and that in Australia is 
that protective effects were excluded from the Australian modelling.  When protective effects were 
removed in the present analysis, very low guideline thresholds were derived (approximately two to 
three units per week).  There are a number of differences between the modelling approaches in this 
report and in Australia which may contribute to this difference; however, a key explanation appears 
to be differences in the baseline mortality rates for individual health conditions in the UK and 
Australia.  These differences lead to higher risk estimates at lower consumption levels in the UK and 
become particularly salient when any cardioprotective effects which counteract these risks are 
removed.  Results are particularly affected if conditions where relative risks are high for moderate 
consumption are more prevalent in the UK compared to Australia or, conversely, if conditions where 
relative risks are low for moderate consumption are less prevalent.  
A recent report by the EU-funded RARHA project investigated for seven European countries the 
consumption levels associated with lifetime alcohol-attributable mortality risks of 1 in 1,000 and 1 in 
100.  The analysis was largely based on the Australian approach; however, there were a number of 
methodological differences.  Four of these are particularly salient.  First, protective effects were 
included in the RARHA analysis.  Second, analyses are only presented for mean consumption and not 
number of drinking days.  Third, the RARHA analysis only considers risks for those aged under 75 and 
argues mortality data for those 75 and older is less accurate with respect to cause of death.  Fourth, 
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it is noted that females have a higher life expectancy and this will exert a downward influence on 
female alcohol-attributable mortality risk up to age 74.  To ensure implied guideline thresholds are 
driven by alcohol-attributable mortality risks rather than overall mortality risks, the RARHA base case 
analysis assumes males and females have the same overall mortality risk.  The alternative scenario of 
different overall mortality risks is examined in a sensitivity analysis and demonstrates implied 
guideline thresholds are lower for males and higher for females when differences in life expectancy 
by sex are included in the analysis.    This sensitivity analysis is the most similar to the analyses 
presented here and the average results across all seven countries for the 1 in 100 threshold give 
implied guideline thresholds which are higher than those in the present report.  The RARHA implied 
thresholds for daily drinkers are 15 units per week for females and 21 units per week for males.   
Confidence in the results presented here is generally increased by a degree of consistency in the 
implied guideline thresholds across studies and countries.  Although the implied guidelines 
thresholds presented here are lower than those within previous studies, they remain of the same 
order of magnitude and different assumptions examined within the sensitivity analyses, particularly 
the reinstatement of threshold effects used in previous versions of SAPM, bring the implied 
guideline thresholds close to those found elsewhere.  The methodological differences described 
should not be overlooked as these may, in part, be responsible for both the lower estimates 
presented here and the general similarity of findings in terms of order of magnitude.  Had the 
present analysis followed the Australian approach of excluding protective effects, the implied 
guideline thresholds would have been starkly different to those found elsewhere (see Sensitivity 
Analysis 2).  Similarly, the decision in the RARHA project to exclude mortality at ages 75 and over 
from the analysis is a major methodological differences from other studies given a large proportion 
of mortality occurs in this older age group.  The impact of this exclusion on implied guideline 
thresholds is difficult to infer as it is dependent on the balance of mortality rates within this age 
group between conditions unrelated to alcohol, conditions related to alcohol but having no potential 
protective effect and conditions related to alcohol and having a potential protective effect.   
Cardiovascular diseases, which have a potential protective effect, tend to be more prevalent in older 
age groups and this suggests that by excluding those aged 75 and over the RARHA analysis may bias 
downwards implied guideline thresholds.   
Overall, the conclusion drawn from comparison with previous studies is that although implied 
guideline thresholds are of similar orders of magnitude, there are a significant number of 
methodological decisions which can impact on the results in different ways depending on the 
country and baseline data under examination.   
 
5.3. Strengths of the analysis 
The analyses presented here are based on the best available evidence on the relationship between 
alcohol consumption and risks of alcohol-related health conditions.  These are (a) systematic reviews 
and meta-analyses of international evidence published in scientific journals, (b) UK-specific evidence 
on the proportion of mortalities and morbidities attributable to alcohol for a set of conditions where 
alcohol has been shown to play a causal role and (c) UK Government datasets detailing alcohol 
consumption, mortality, morbidity and population demographic data.   
56 
 
These data are synthesised to produce risk estimates using the Sheffield Alcohol Policy Model 
(SAPM), a well-established modelling framework which has previously been used in influential 
analyses of alcohol policies published by the National Institute for Health and Care Excellence32 and 
in leading scientific journals.27,28,31  A particular strength of SAPM is the simultaneous consideration 
of a wide range of alcohol-related health conditions arising from both regular long-term alcohol 
consumption and episodes of heavy drinking.  A range of sensitivity analyses are provided for 
consideration by readers to aid understanding of how the results vary when using alternative 
assumptions, evidence or methodologies.  Further narrative discussion of uncertainty to aid readers’ 
understanding of the results is provided in Sections 5.4 and 0 below.   
Analyses of risk are presented in several ways, allowing consideration of different alcohol 
consumption patterns, different outcomes (mortality and morbidity) and different metrics of risk 
(relative risk, proportion of deaths attributable to particular causes).  Separate analyses are 
presented for males and females and the effects and challenges of separating analyses by age are 
also shown.   
5.4. Limitations 
When using the results presented above, it is important to be aware of limitations in both the 
underlying epidemiological evidence base which provides the inputs to SAPM and the SAPM 
methodology itself.  Given their importance to the application of the Canadian and Australian 
methods, the key limitations are discussed in some detail below; focusing first on general limitations 
of the epidemiological evidence followed by limitations specific to SAPM.   
5.4.1. Limitations of epidemiological evidence 
The epidemiological evidence detailing relationships between alcohol consumption and risks to 
health is primarily derived from meta-analyses of case control and cohort studies.  Evidence used in 
SAPM was identified via a systematic review of reviews to identify the most recent high quality 
meta-analyses.   Those studies provide detailed information on the risks associated with alcohol and 
play an important role in public health analyses such as the Global Burden of Disease studies.73  
However, the studies also have widely acknowledged limitations relating to the underestimation of 
alcohol consumption and further biases which some scientists argue are key reasons for the 
observation of cardioprotective effects from moderate drinking.  These points are discussed in turn. 
5.4.1.1. Underestimation of alcohol consumption 
SAPM requires as model inputs survey data on alcohol consumption and also draws on evidence 
linking consumption to health risks.  In both cases, the alcohol consumption data typically 
underestimate levels of drinking when compared with more robust aggregate data (e.g. tax or sales 
data).  Depending on the country and the survey method used, this underestimation can be such 
that surveys only account for between 40% and 70% of alcohol known to be sold in a given year.74,75  
The UK surveys used within SAPM account for approximately 60-70% of alcohol cleared for sale by 
HMRC.76  This means risks of drinking are commonly derived from data which significantly 
underestimate the levels of alcohol consumption taking place.  There are a number of reasons for 
this underestimation and, in particular, surveys are potentially subject to bias from four main 
sources.   
First, cohort studies estimating risks of alcohol consumption using surveys often exclude certain 
population groups whose drinking differs from the general population.  For example, surveys of 
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private households exclude those in nursing homes, psychiatric institutions, prisons and the military, 
students living in halls of residence and the homeless.  Other groups are included in the sample but 
are substantially under-represented.  A key example of this are dependent drinkers and a recent 
analysis estimated that, after weighting, the 2006 UK General Lifestyle Survey under-represented 
dependent drinkers by approximately 50%.76  Surveys of UK clinical populations also suggest that 
dependent drinkers sampled in general population surveys have lower alcohol consumption levels 
than the wider dependent drinker population.77,78   
Second, studies estimating risks from alcohol consumption vary in the questions they use to 
measure that consumption.  This variation in survey questions used leads to markedly different 
levels of underestimation of consumption relative to aggregate sales or tax data.79  For example, all 
of the following have been shown to alter substantially consumption estimates: asking about 
consumption for each beverage type in turn, asking about frequency of consuming at different 
consumption levels, extending the reference period for the question (e.g. over the last week, month, 
6 months or year) and asking about both typical and heavy drinking occasions.80   
Third, there may be inaccuracies in self-reports of drinking behaviour even when sampling and 
questionnaires are well-designed.  People may over- or under-report their drinking for reasons of 
social desirability,81 inaccurately recall how much they drank or lack of sufficient knowledge to 
provide accurate reports.82-84  For example, a consistent finding is that drinkers underestimate the 
volume of liquid in self-poured drinks of spirits.  Self-reports of consuming one unit of spirits are 
seen to correspond to drinks which contain on average two or more units.85-87  This is particularly 
significant as it suggests a relationship between the beverages people drink, the locations they drink 
them (as self-poured spirits will typically not be drunk in bars or restaurants) and the extent of error 
in self-reported consumption data.   This means self-report error is likely to vary across the 
population.   
Fourth, after collecting data on drinks consumed, it must then be converted into units of alcohol as 
detailed information on alcoholic content are rarely collected from respondents.  Where data have 
not been collected for each beverage type separately, there is a high risk of measurement error as 
participants or researchers attempt to convert a potentially diverse portfolio of drinks (e.g. strong 
beer, double whisky, large red wine, small white wine) into an estimate of total units consumed.   
Even where beverage-specific data have been collected, this still requires researchers to apply 
assumptions regarding average alcoholic strengths of drinks.  These assumptions may be appropriate 
for the total population but if certain population groups tend to prefer stronger or weaker variants 
of beer, wine or spirits, their consumption estimates are likely to be biased   
The above biases are near-ubiquitous within alcohol epidemiology and methods for adjusting data to 
account for them are not well-developed.  In particular, methods accounting for variation in 
underestimation across the population are lacking.76,88,89  Key barriers are a lack of gold standard 
individual-level data against which to assess surveys and resultant limited understanding of the 
extent to which consumption is under- or overestimated for different groups within the 
population.90   
These biases do not fundamentally undermine the wide range of research undertaken using alcohol 
consumption data to investigate the impact of alcohol on health.  The 43 alcohol-related health 
conditions selected for use within SAPM are chosen because there is robust evidence that alcohol 
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plays a causal role in their occurrence.44  Although epidemiological evidence of the kind discussed 
here is crucial for quantifying associations between alcohol consumption and each condition, it is 
only one of several kinds of evidence which are used to assess whether alcohol is playing a causal 
role.91  Other types of evidence (e.g. plausible biological mechanisms, findings from laboratory 
studies and the coherence and consistency of findings across all research) also play an important 
role.  Similarly important is the consistent dose-response nature of the findings whereby, after 
accounting for any cardioprotective effects (see Section 5.4.1.2) risk typically increases in line with 
consumption.  Although the precise level of risk associated with a given level of consumption may be 
subject to uncertainty, evidence that high levels of consumption entail greater risk than low levels of 
consumption is robust.   Finally, analyses of alcohol consumption data have shown that, while 
consumption levels may be underestimated, many survey techniques are still able to reliably identify 
drinkers who are heavier and lighter drinkers and, consequently, those at lower and higher risk from 
their drinking.92,93   
In conclusion, the limitations discussed above do mean that caution must be applied when 
interpreting individual quantifications of risk associated with a particular level of consumption.  
However, those quantifications remain of value as indicators of the level of risk associated with a 
particular consumption level or pattern and, particularly, as indicators of how that level of risk 
compares to alternative consumption levels or patterns.  Moreover, they represent the best 
available evidence of risk levels from alcohol consumption and should form part of any consideration 
of what constitutes low risk drinking.   
5.4.1.2. Debate regarding cardioprotective effects 
An extensive literature including well-executed meta-analyses of high quality primary studies have 
found an association between moderate drinking and reduced risk of cardiovascular disease and 
particularly ischaemic heart disease.  For example, a systematic review and meta-analysis of 24 
studies found male mortality risk for ischaemic heart disease was lowest among those drinking an 
average of four units of alcohol per day and risk remained lower than that of abstainers up to 
approximately eight units per day.  Other health conditions included in SAPM where there is 
evidence of protective effects are ischaemic and haemorrhagic stroke, type II diabetes and 
hypertensive diseases (i.e. diseases arising from high blood pressure).   
This literature has attracted substantial debate regarding whether evidence is sufficient to conclude 
that low levels of alcohol consumption have a causal relationship with improved cardiovascular 
health.  The debate includes detailed critique of both observational and meta-analytic studies, 
exploration of potential biological mechanisms explaining observed cardioprotective effects and 
arguments regarding the public health relevance of establishing the veracity of cardioprotective 
effects given alcohol’s undisputed risk for other diseases and the various alternative options for 
reducing cardiovascular risk.10,12,13,17,94  The key arguments suggesting cardioprotective effects may 
be over-estimated by standard epidemiological analyses are outlined below.   
First, there is evidence that participants in epidemiological cohort studies may differ with regard to 
their underlying health status compared to the general population.  One reason for this is such 
studies often recruit participants with no underlying health conditions at baseline.13,95  The resulting 
potential for bias was demonstrated in a major European prospective cohort study which included at 
baseline people with chronic disease.  Risk estimates were calculated for both the whole cohort and 
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for a subsample of the cohort who were free of chronic disease at enrolment.14  Relative risk of 
cardiovascular mortality was lowest in those with light to moderate alcohol use; however, this was 
only the case among the subsample free from chronic disease at enrolment.  This suggests sample 
selection processes for typical cohort studies may disproportionately exclude those at cardiovascular 
risk from moderate drinking leading to overestimation of any cardioprotective effect.   
Second, estimates of risk relationships between alcohol consumption and health conditions are 
commonly quantified by calculating the risk of a given level of consumption relative to the risk of 
zero consumption (i.e. abstention).  In practice, this means  assuming that, after controlling for a 
range of confounding factors such as age and gender, drinkers and abstainers only meaningfully 
differ in terms of their alcohol consumption and a narrow set of other factors.  This assumption has 
been questioned and the characteristics of abstainers and their similarity to the general population 
have been closely scrutinised.20-25,96  Most significantly, the classification of former drinkers as 
abstainers has raised particular concerns, particularly where those former drinkers have stopped 
drinking due to health problems.  Meta-analyses which disaggregate abstainers (e.g. never drinkers, 
former drinkers, occasional drinkers) have concluded that using a single abstainer category leads to 
overestimation of the cardioprotective effect of alcohol.15,16,18   
Third, alcohol consumption is typically measured in epidemiological studies of long-term health risks 
as average daily consumption.  However, recent evidence incorporating data on frequency of heavy 
drinking occasions (defined as more than 7.5 units on a single day) has shown an elevated ischaemic 
heart disease risk for moderate drinkers who have heavy drinking occasions at least once per month 
when compared to moderate drinkers with fewer heavy drinking occasions.61  Further analyses 
suggest any cardioprotective effect from moderate drinking may be attenuated or no longer present 
among those who have heavy drinking occasions at least monthly.97,98 
Fourth, alcohol consumption is only one of many variables which have a positive or negative 
association with an individual’s cardiovascular risk and it has been argued that “groups with different 
drinking habits differ in several other ways than their drinking, making it difficult to separate the 
effects of drinking habits from other factors”.10 p.2  For example, both increasing age and smoking 
status increase individual risk of ischaemic heart disease and estimated risk relationships for alcohol 
consumption can be adjusted to account for these confounding factors.97  However, a recent major 
meta-analysis noted substantial unexplained heterogeneity in risk estimates suggesting other 
important confounding factors were not controlled for.18 
Evidence that cardioprotective effects may be overestimated is relevant here for three reasons: (1) 
the results presented above are highly sensitive to the removal of any protective effects; (2) 
potential cardiovascular effects of moderate drinking have informed previous guideline 
development processes1,6 and (3) many of the studies which suggest cardioprotective effects are 
overestimated identify biases which are equally present in most epidemiological analyses of this kind 
(i.e. in estimated risk relationships between alcohol consumption and other non-cardiovascular 
health conditions).  Indeed protective effects have been found for a plethora of unrelated health 
conditions with little evidence of plausible biological mechanisms to explain many of the 
associations.10   
Given these critiques, there is little consensus in the scientific community regarding the presence or 
size of any cardioprotective effect.   Evidence supporting the effects undoubtedly exists and the 
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association between moderate drinking and reduced cardiovascular risk is consistently observed 
within epidemiological analyses.  However, interpretations of this finding vary and there are strong 
reasons to conclude the effect is, at the least, overestimated within standard epidemiological 
analyses and limited to certain groups within the population (e.g. those with fewer heavy drinking 
occasions, particular demographic characteristics and particular health behaviours).  Crucially, the 
methodological issues which give rise to these beliefs are not limited to studies of cardiovascular 
risk.  They apply equally, creating greater or lesser degrees of bias, to studies of other health 
conditions.  The potential effect of those further biases has not been quantified in the present 
report.   
5.4.1.3. Further limitations of epidemiological analyses 
In addition to those points raised in the debate regarding cardiovascular risk a further set of 
common limitations in primary epidemiological studies or meta-analyses of those studies are 
relevant.  These include: 
 Relating consumption at a single point in time to health outcomes rather than a trajectory of 
consumption across the period of time during which the health condition developed;99 
 Not accounting for systematic differences in health risks between individuals with the same 
average daily consumption but different drinking patterns;11  
 Synthesising within meta-analyses different measures of alcohol consumption from primary 
studies or creating categorical consumption measures (e.g. 1-3 units per day, 4-6 units per 
day) which reduce the precision of consumption estimates.16,18 
5.4.1.4. Summary 
The above discussion highlights that, as with all research, epidemiological analyses estimating risk 
relationships between alcohol consumption and health outcomes are subject to important 
limitations.  As with self-reported alcohol consumption data, there is no suggestion in the research 
literature that the limitations discussed above fundamentally undermine evidence of causal 
relationships between alcohol consumption and the 43 alcohol-related health conditions modelled 
here.  Again, a range of alternative evidence beyond epidemiological analyses supports the 
conclusion that alcohol is a causal agent for those conditions44 and consistently observed dose-
response relationships support conclusions that higher levels of risk occur for heavier drinkers.  
Moreover, research methods have developed to account for limitations as they have been identified 
(e.g. it is now common practice to attempt to exclude studies from meta-analyses if they do not 
disaggregate never drinkers from former drinkers).  However, the limitations do imply that the 
estimated risk for any given level of alcohol consumption is subject to a degree of uncertainty 
beyond that provided by the confidence intervals or standard errors reported in most studies.  The 
scale of this uncertainty is likely to be substantial as, for example, the evidence from available 
analyses described above suggests particular limitations can lead to large observed cardioprotective 
effects being called into question.  The sensitivity analyses for this report further suggest that 
excluding those effects has a large impact on average risk estimates across all alcohol-related health 
conditions.   
Quantifying the overall effect on risk estimates of the uncertainty in the data used by SAPM is 
challenging.  Evidence is lacking on variation in underestimation of alcohol consumption across the 
population and on the influence of different drinking patterns on risk estimates for most diseases.  
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Although the effects of some limitations on risk estimates for ischaemic heart disease are reasonably 
well understood, 10,100 the effects of other limitations and the effects on risk estimates for other 
conditions are less widely researched.  A small number of studies have attempted to model the 
effects of these limitations on various alcohol epidemiology metrics and provide indications of the 
potential scale of uncertainty around risk estimates.  Examples of this approach include studies 
examining how the impact of different adjustments to alcohol consumption data affect levels of 
underestimation and estimated levels of alcohol-attributable mortality.   Results have shown 
underestimation of alcohol consumption data may lead to the number of alcohol-attributable cases 
for a range of conditions (including key diseases such as liver cirrhosis) being underestimated by 
between 30% and 40%.76,88,101   Note that this does not mean the results presented here are 
necessarily subject to the same 30-40% degree of uncertainty as there are a large number of steps 
between calculating numbers of alcohol-attributable mortalities and producing modelled estimates 
of risks relationships.  The authors are, however, unaware of any modelling study which seeks to 
simultaneously account for a wide range of the limitations discussed above and thus produces a 
comprehensive quantified uncertainty estimate.  
In the absence of quantification, evidence-based judgements can be made as to the broad effects of 
different biases.  For example, while underestimation of alcohol consumption has been shown to 
lead to underestimation of AAFs, it is also likely to lead to overestimation of risks as each measured 
consumption level corresponds to a higher actual consumption level.   Similarly, classifying former 
drinkers as abstainers will increase the mortality rate in this group and bias downwards risks for 
current drinkers leading to underestimation of consumption risks.  Finally, quantified effects of 
limitations for one alcohol-related outcome can often be used to inform understanding of similar 
effects for other outcomes.  A key example of this is considering how critiques of the epidemiology 
of cardioprotective effects may impact on other alcohol-related risk estimates.  Overall, however, 
the absence of a comprehensive analysis of uncertainty means such judgements can only provide 
guidance for considering the results  
The implications of these points for the Guideline Development Group’s use of the results presented 
above will be discussed after outlining limitations in the SAPM methodology which also require 
consideration by the group.   
5.4.2. Limitations of SAPM 
SAPM is subject to a number of limitations which are discussed in previous technical reports.32,70  
These include many of the limitations outlined above but also include a number of limitations of 
particular relevance to the modelling undertaken for the present report.  These are discussed in turn 
below. 
First, modelling of the relationship between single occasion alcohol consumption and acute alcohol-
related health conditions is limited by the available consumption data and previous evidence on 
such risks.  UK datasets which include the large sample size and mean weekly consumption 
estimates required by SAPM only characterise single occasion consumption via the heaviest drinking 
day in the week preceding the survey.  This measure is unusual internationally and thus links poorly 
to the wider epidemiological evidence base on acute alcohol-related health risks.102-104  It also 
captures only one dimension of single occasion consumption (quantity) and does not capture 
important additional dimensions (e.g. frequency of heavy consumption or variability in consumption 
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across occasions).80,105  To partially account for this, the analyses of mean weekly consumption by 
number of drinking days examines the extreme scenarios where a given mean weekly level is 
consumed evenly across seven days (thus minimising acute risk) and consumed on a single day (thus 
maximising acute risk).  Assuming drinkers consume at least weekly, the risks for all possible drinking 
patterns fall between these minimum and maximum risk scenarios.  Therefore, to the extent that 
risks for the extreme scenarios are correctly estimated, a range of possible values for the implied 
guideline threshold can be identified.   
Second, the epidemiological evidence base on acute risks is also limited as, unlike chronic alcohol-
related health risks, there are few meta-analyses deriving risk functions linking single occasion 
consumption measures to specific health risks.   SAPM accounts for these limitations in the available 
evidence by calibrating risk functions to AAFs or absolute case numbers for health conditions as 
outlined in Section 3.5.   These risk functions are assumed to be linear in the absence of compelling 
evidence for alternative specifications.   This assumption is also applicable to risk functions 
calibrated for wholly-attributable chronic health conditions.  Further assumptions are also required 
regarding thresholds below which risks are identical to those of abstainers.  Sensitivity analyses 
around those assumptions are provided.   
Third, there is evidence that risk of alcohol-related health harm varies by socioeconomic status 
independent of alcohol consumption.106  Although this has been accounted for in recent versions of 
SAPM,27 the present version does not do so due to inconsistencies in the definition of socioeconomic 
status across the mortality and morbidity data available for each country.   
Fourth, as no data are available on condition-specific morbidity prevalence in the general 
population, risk curve estimates for morbidity are based on a more limited definition of morbidity; 
specifically morbidity leading to one or more hospital admission(s).   
Fifth, no measures of statistical uncertainty are provided around the risk estimates presented in the 
results.  This is because the modelling uses sources of evidence which often do not report 
confidence intervals.  Further, the limitations in the evidence and in SAPM itself which are discussed 
above contribute additional and substantial methodological uncertainty.  This means any confidence 
intervals presented would, in one sense, be misleading as they pertain to only one part of the 
uncertainty which is known to exist around any given risk estimate.  Therefore, in addition to 
presenting a comprehensive discussion of this uncertainty for consideration by readers, the 
uncertainty is also examined via set of scenario analyses investigating the sensitivity of the results to 
particular alternative assumptions, evidence or modelling methodologies.  These are presented in 
Section 4.5. 
Finally, risk estimates are provided for mortality and morbidity separately with no single metric 
provided which integrates these (e.g. quality adjusted life years or QALYs).  The potential life years 
lost at different consumption levels also not provided and this introduces uncertainty regarding the 
extent to which premature mortalities are at younger or older ages.  SAPM is not currently able to 
produce these metrics for the present analyses and this point is discussed further in the directions 
for future research (Section 5.6.1).  
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5.5. Consideration for using the results to inform selection of new lower 
risk drinking guideline thresholds 
It is beyond the scope of this project report to make specific recommendations on appropriate 
guideline thresholds or to specify the processes the Guideline Development Group should follow 
when using this report.  However, alongside other evidence considered by the group, the following 
section should usefully inform consideration of the model results and the accompanying 
commentary.   
A critical over-arching conclusion which informs this section is that a number of expert judgements 
will be required by the Guideline Development Group to translate the model results and other 
available evidence into proposed guideline thresholds.  Despite the recent shift in guideline 
development processes away from ‘opaque collective expert opinion’5 and toward transparent 
empirically-driven methods,3  the points made will highlight that expert judgement cannot be 
removed from the process.  Therefore, those reading this report should not expect that any 
guideline which emerges from the review process is solely a product of the numerical analyses 
presented.  The final decision on a guideline threshold must represent a holistic expert judgement by 
the Guideline Development Group accounting for the modelling results, the various points raised in 
this discussion and further evidence sources and considerations identified in the group’s 
deliberations.   
5.5.1. Considerations relating to limitations in the available evidence 
The strengths and limitations in the epidemiological evidence base and in the SAPM methodology 
are discussed in Sections 5.4.1 and 5.4.2.  Sensitivity analyses around assumption made in the 
modelling are also provided in Section 4.5.  These highlight that:  
 Clear and scientifically-robust conclusions can be drawn regarding the broad levels of risk 
associated with different levels and patterns of alcohol consumption.  For example, it is clear 
that, above the level where any protective affects occur, mortality and morbidity risks increase 
with increasing consumption.  Therefore, there is robust evidence that, for example, consuming 
50 units of alcohol per week carries substantially greater mortality and morbidity risks than 
consuming 20 units of alcohol per week.   
 The level of risk associated with a particular level of mean weekly consumption varies depending 
on the pattern of consumption (e.g. weekly vs. daily consumption) as this exposes the drinker to 
greater or lesser levels of intoxication-related risk and cardiovascular risk.61,107  The extent of this 
variation is not consistent across the population and depends on each population group’s 
balance of baseline risk for acute and chronic alcohol-related conditions.   
 The consumption levels at which the Canadian or Australian definitions of low risk drinking are 
exceeded are subject to uncertainty due to limitations in the available evidence.  Sensitivity 
analyses illustrate that some aspects of this uncertainty have a modest but noteworthy impact 
on risk estimates (e.g. uncertainty around threshold effects where risk functions are calibrated) 
and others aspects have large impacts (e.g. uncertainty around threshold effects within risk 
function and the veracity of cardioprotective effects from moderate drinking).  Further evidence 
from studies examining this uncertainty does not provide quantifications of uncertainty around 
risk estimates based on simultaneous consideration of all principal sources of uncertainty; 
however, it does provide evidence on the effects of several individual sources of uncertainty.  
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This evidence can be considered alongside the results presented here when selecting lower risk 
drinking guideline thresholds. 
5.5.2. Considerations relating to variations in risk across the population 
The results present guidelines for males and females and an analysis of variation in risk by age.  
These results highlight that: 
 Males and females and different age groups experience different types of risk and different 
degrees of risk as a result of alcohol consumption.  This variation is reflected in the risk 
estimates presented above.   The Guideline Development Group should consider whether 
the implied guideline thresholds support separate lower risk guidelines for males and 
females for mean weekly consumption.  
 Using the Canadian or Australian approaches to derive lower risk drinking guidelines for each 
age group based on age-specific risk curves is not recommended.  Sections 4.4 and 5.1 
illustrate how this produces guideline thresholds which vary markedly and sometimes 
counter-intuitively by age.  Some of the guideline thresholds which would be derived are 
likely to lack credibility with the public and other stakeholders.  This occurs because both the 
Canadian and Australian approach rely on the averaging of very different risk profiles across 
age groups.  These risk profiles emerge from different balances of acute and chronic health 
risks across the population and further differences in absolute levels of health risk from all 
causes.   
 The rationale for both the Canadian and Australian approaches is to employ a transparent 
and conceptually robust definition of low risk in selecting the guideline threshold.  In both 
cases, it is argued that the guideline corresponds to a defensible definition of low risk.  The 
Guideline Development Group may wish to consider to what extent that rationale is 
undermined by (a) the difficulty of applying either definition of low risk to certain age groups 
and (b) the population guideline being based on the average of highly diverse risks across 
the population and thus not corresponding directly to any one group’s risk profile.    
 Similar arguments may be made with regard to other individual characteristics which are 
associated with health outcomes and not examined in this report.  These include 
socioeconomic status, health status, psychological dispositions, engagement in other health-
related behaviours, genetic profile and personal health and health behavioural history.   
 Public health guidelines must inevitably strike a balance between being specific enough to 
reflect variations in risk across the population and remaining sufficiently broad to be 
communicable via population-level health promotion campaigns.  One approach to 
addressing heterogeneity in risk across the population is for the Guideline Development 
Group to consider who the key target populations for each guideline are and, where 
population-level guidelines are used (e.g. on bottle labels or television advertising where 
space is limited), ensure the guidelines are appropriate for those target populations.   
5.5.3. Considerations relating to alternative guidelines and alternative means of 
selecting guideline thresholds 
This report has provided a number of risk curves presenting implied guideline thresholds (a) under 
the Canadian and Australian approaches, (b) for different measures of alcohol consumption and (c) 
for mortality and morbidity.  These results highlight that: 
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 The differences between implied guideline thresholds across analyses are modest in most 
cases.   
 The range of implied thresholds for mean weekly consumption are generally lower in the 
base case model than those used in the current UK lower risk drinking guidelines and in the 
Canadian and Australian drinking guidelines which are partly based on similar modelling 
exercises     
 The current UK drinking guidelines do not include a single occasion guideline.  As explained 
in the Summary of Results (Section 5.1.1), the Canadian and Australian approaches offer no 
straightforward means for deriving such a guideline and the Guideline Development Groups 
in those countries based their single occasion guidelines on reviews of the relevant 
literature.   
 If the UK Guideline Development Group wishes to propose a single occasion drinking 
guideline, the authors of this report recommend the approach outlined in Section 5.1.1 
which relies on the group balancing (a) evidence in Table 16 on mortality risks associated 
with consumption on different numbers of drinking days, (b) the drinking patterns including 
number of drinking days per week among the population at whom a single occasion 
guideline is targeted and (c) literature-based evidence such as that considered by the 
Canadian and Australian approach.  
 The notion of ‘drink-free days’ is part of the UK Government’s ‘Change for Life’ campaign.108  
The House of Commons Science and Technology Committee also noted it was an important 
aspect of drinking guidelines based on daily, as opposed to weekly, consumption limits.1  The 
analyses provided here link implied guidelines thresholds to number of drinking days, but 
this is a means of examining the balance of risks associated with low level regular drinking 
vs. occasional heavy drinking.  It does not account for any potential additional benefits 
directly resulting from drink-free days via, for example, allowing the liver to recover 
following a heavy drinking occasion or disrupting habitual drinking behaviours.  Rehm et al. 
recently argued “the scientific basis for alcohol-free days is scarce, especially for light to 
moderate drinking” while also noting well-established links between daily drinking and 
increased alcohol use disorder risk and indications that drink-free days may contribute to 
reduced mortality among heavy drinkers as a result of relieved liver function.72 p.37  
Therefore, it is recommended that the Guideline Development Group focus any discussion of 
drink-free days on (a) clarifying that a daily drinking guideline does not imply one should 
drink daily and (b) potential but unproven benefits for reducing liver damage and habitual 
drinking risks among heavier drinkers. 
 A number of important outcomes related to alcohol consumption are not modelled here and 
should be considered.  These include social risks to the individual (e.g. risks of being a victim 
of crime, negative consequences for family well-being and for income and employment) and 
risks of others being harmed by an individual’s drinking (e.g. alcohol-attributable crime, 
intimate partner violence, worsened child development and macroeconomic impacts 
through reduced productivity).  Evidence relating to these risks is less well-developed than 
for health risks; however, evidence of varying strengths for a causal effect from alcohol 
consumption is present in many cases.109-112   
 Finally, with the exception of any cardioprotective effects of moderate drinking, this report 
has focused exclusively on the negative consequences of drinking.  The Guideline 
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Development Group may wish to give consideration to the positive reasons people choose 
to drink and any potential benefits to well-being they receive from doing so.  There is very 
little quantitative evidence in this area which could be incorporated within SAPM and this 
reflects difficulties in quantifying such benefits.113  However, there are qualitative and 
ethnographic literatures on the reasons people choose to drink and the positive 
consequences for well-being they report from doing so114,115  The Group may wish to 
consider this literature alongside evidence on the negative consequences of drinking.   
5.6. Directions for future research 
5.6.1. Extensions to the present research 
The analyses above could be extended in two main ways:   
First, the present analysis relied on combining data sources already held by the University of 
Sheffield.  This meant certain analyses, particularly of morbidity, were not possible due to the 
absence of necessary data which could be obtained if required.   
Second, the analysis of mortality does not include in its results the distribution of mortalities across 
age groups (although this is modelled) and thus does not account for potential years of life lost 
(PYLL).  Further, it treats mortality and morbidity separately rather than integrating them within a 
single metric such as that provided by QALYs (quality adjusted life years) which measures life years 
lost and also losses from years lived without full health.  It is possible in theory to repeat analyses 
using the Canadian approach using PYLL or QALYs rather than mortalities; however, it would be 
more challenging to do this using the Australian approach.  This is because substantial revisions to 
SAPM would be required to calculate the PYLL and QALYs for other causes.  These calculations are 
required to estimate the proportion of PYLL and QALY losses attributable to alcohol.   
5.6.2. Wider research needs 
A key limitation of the research which is discussed extensively above is the uncertainty in the 
available evidence measuring alcohol consumption and quantifying risk relationships between 
alcohol consumption and health outcomes.  Research is required to increase understanding of the 
impact of this uncertainty on risk estimates and, potentially, increase precision of risk estimates.  
Specific research needs include:  
 Further investigation of the impact of underestimation of alcohol consumption on 
epidemiological evidence relating to alcohol consumption and in particular its effects on 
AAFs and risk estimates; 
 Further investigation of the variation in underestimation of alcohol consumption across 
individuals and population groups; 
 Investigation of how the biases which are shown to affect estimates of cardioprotective 
effects from moderate alcohol consumption also affect risk estimates for other conditions 
where no protective effects are observed; 
 Further development of methods to synthesise statistical uncertainty estimates (i.e. 
confidence intervals) from multiple sources when undertaking modelling exercises such as 
SAPM; 
 Development of methods for simultaneously addressing all or many components of the 
above and allowing for comprehensively adjusted risk estimates to be produced. 
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A further key area requiring development in alcohol epidemiology is the relationship between health 
outcomes and complex patterns of drinking (e.g. average consumption, frequency of consumption, 
peak consumption and variability in consumption across drinking occasions) and the shifting of these 
patterns across the life course.  Research is beginning to emerge in this area;36,37,61,65,99 however, 
further understanding is required across the broad range of health outcomes related to alcohol and 
in the detail of how different drinking patterns explain variation in risks across the population. 
Also important for the tailoring of drinking guidelines and risk estimates is an improved 
understanding of the context-specificity of risks and how acute risks in particular are affected by the 
drinking context (e.g. company, location, type of occasion).  Currently, alcohol epidemiology is 
strongly informed by an ‘exposure-outcome’ paradigm which is built around metrics of ethanol 
consumption and ICD codes.  Although informative, this method does not given attention to the fact 
that drinking alcohol is a socially embedded behaviour where many risks of concern to policy makers 
(e.g. social disorder, family well-being) are less objectively defined than health conditions and which 
are rooted in the interaction between alcohol consumption and the contexts in which it occurs.  
Emerging research examining alcohol’s harm to those other than the drinker110,116-121 and the nature 
of drinking occasions122 are examples of research moves in this direction.   
With regard to data, the UK has a strong legacy of cohort studies permitting analyses of alcohol 
consumption-related risk; however, it is in a deteriorating position with regard to the general 
population surveys which underpin SAPM and other valuable research.  The long-running General 
Lifestyle Survey (GLF) was discontinued in 2011, ending a time series on alcohol consumption which 
had run over 35 years.  No annual, UK-wide, large sample survey has been established to collect 
equivalent data.  Longitudinal panel data collected in the later years of the GLF has not been cleaned 
by the Office for National Statistics and is thus not being made available to researchers.  The health 
surveys of the individual UK countries have smaller samples than the (GLF) and must be synthesised 
by the researcher for UK-wide analysis.  This process is hindered as the same data are not collected 
in each country.  In some cases the data collected are of poor quality and do not conform to 
international recommendations102-104 (e.g. the Health Survey for Wales only collects data on the 
heaviest drinking day in the preceding week; a measure of little value for much alcohol research as 
the crucial measure of average daily or weekly consumption cannot be derived from it).  The new 
UK-wide panel study, Understanding Society, will collect alcohol consumption data intermittently 
but, again, alcohol consumption measures used do not conform to international recommendations 
and will present difficulties for researchers seeking to work within established international research 
paradigms.  A strong recommendation of this report is for the Office for National Statistics and 
others involved in the design of UK alcohol consumption surveys to give greater regard to the needs 
of researchers using those surveys.  An important first step would be establishing consistent data 
collection standards conforming to international recommendations across all UK surveys collecting 
information on alcohol consumption.   
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